JP6235779B2 - Folic acid-containing composition and method for stabilizing folic acid - Google Patents
Folic acid-containing composition and method for stabilizing folic acid Download PDFInfo
- Publication number
- JP6235779B2 JP6235779B2 JP2012287329A JP2012287329A JP6235779B2 JP 6235779 B2 JP6235779 B2 JP 6235779B2 JP 2012287329 A JP2012287329 A JP 2012287329A JP 2012287329 A JP2012287329 A JP 2012287329A JP 6235779 B2 JP6235779 B2 JP 6235779B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- folic acid
- extract
- component
- folic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 title claims description 260
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 title claims description 130
- 235000019152 folic acid Nutrition 0.000 title claims description 130
- 239000011724 folic acid Substances 0.000 title claims description 130
- 229960000304 folic acid Drugs 0.000 title claims description 129
- 239000000203 mixture Substances 0.000 title claims description 59
- 238000000034 method Methods 0.000 title claims description 28
- 230000000087 stabilizing effect Effects 0.000 title claims description 14
- 238000002360 preparation method Methods 0.000 claims description 37
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 33
- 238000002156 mixing Methods 0.000 claims description 31
- 150000003839 salts Chemical class 0.000 claims description 30
- 239000002537 cosmetic Substances 0.000 claims description 26
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 18
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 15
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 15
- 239000004472 Lysine Substances 0.000 claims description 15
- 229920002125 Sokalan® Polymers 0.000 claims description 15
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims description 10
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 10
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims description 10
- 229960002591 hydroxyproline Drugs 0.000 claims description 10
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims description 10
- 239000004475 Arginine Substances 0.000 claims description 9
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 9
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 9
- 239000004310 lactic acid Substances 0.000 claims description 9
- 235000014655 lactic acid Nutrition 0.000 claims description 9
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 8
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 8
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 6
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 6
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 5
- 230000006641 stabilisation Effects 0.000 claims description 5
- 238000011105 stabilization Methods 0.000 claims description 5
- 239000000284 extract Substances 0.000 description 72
- -1 amino acid salts Chemical class 0.000 description 54
- 235000002639 sodium chloride Nutrition 0.000 description 32
- 210000003491 skin Anatomy 0.000 description 29
- 230000008859 change Effects 0.000 description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 19
- 229940024606 amino acid Drugs 0.000 description 18
- 235000001014 amino acid Nutrition 0.000 description 18
- 235000014113 dietary fatty acids Nutrition 0.000 description 17
- 235000019441 ethanol Nutrition 0.000 description 17
- 229930195729 fatty acid Natural products 0.000 description 17
- 239000000194 fatty acid Substances 0.000 description 17
- 230000000694 effects Effects 0.000 description 16
- 150000001413 amino acids Chemical class 0.000 description 15
- 239000008213 purified water Substances 0.000 description 15
- 239000003795 chemical substances by application Substances 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- 239000004166 Lanolin Substances 0.000 description 13
- 235000019388 lanolin Nutrition 0.000 description 13
- 229940039717 lanolin Drugs 0.000 description 13
- 239000007788 liquid Substances 0.000 description 13
- 229960003646 lysine Drugs 0.000 description 13
- 235000018977 lysine Nutrition 0.000 description 13
- 238000004519 manufacturing process Methods 0.000 description 13
- 239000003921 oil Substances 0.000 description 13
- 235000019198 oils Nutrition 0.000 description 13
- 239000000843 powder Substances 0.000 description 13
- 238000001556 precipitation Methods 0.000 description 13
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 12
- 238000002845 discoloration Methods 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 11
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 11
- 235000013361 beverage Nutrition 0.000 description 11
- 238000011156 evaluation Methods 0.000 description 11
- 235000011187 glycerol Nutrition 0.000 description 11
- 239000004615 ingredient Substances 0.000 description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- 239000002253 acid Substances 0.000 description 10
- 235000013305 food Nutrition 0.000 description 10
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 10
- 239000006210 lotion Substances 0.000 description 10
- 239000000049 pigment Substances 0.000 description 10
- 244000269722 Thea sinensis Species 0.000 description 9
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 9
- 239000007864 aqueous solution Substances 0.000 description 9
- 235000015165 citric acid Nutrition 0.000 description 9
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 9
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- 235000009697 arginine Nutrition 0.000 description 7
- 229960003121 arginine Drugs 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 239000010445 mica Substances 0.000 description 7
- 229910052618 mica group Inorganic materials 0.000 description 7
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 7
- 235000019799 monosodium phosphate Nutrition 0.000 description 7
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 7
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 7
- 229920003169 water-soluble polymer Polymers 0.000 description 7
- 229940058015 1,3-butylene glycol Drugs 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 6
- 229910019142 PO4 Inorganic materials 0.000 description 6
- 235000006468 Thea sinensis Nutrition 0.000 description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 6
- 235000019437 butane-1,3-diol Nutrition 0.000 description 6
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 6
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 239000002304 perfume Substances 0.000 description 6
- 239000010452 phosphate Substances 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 239000003381 stabilizer Substances 0.000 description 6
- 235000013616 tea Nutrition 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical group C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 5
- 229960003237 betaine Drugs 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 229920002678 cellulose Polymers 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 5
- 239000007857 degradation product Substances 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 235000013311 vegetables Nutrition 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 4
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- MSTNYGQPCMXVAQ-KIYNQFGBSA-N 5,6,7,8-tetrahydrofolic acid Chemical compound N1C=2C(=O)NC(N)=NC=2NCC1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 MSTNYGQPCMXVAQ-KIYNQFGBSA-N 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- 239000004375 Dextrin Substances 0.000 description 4
- 229920001353 Dextrin Polymers 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 235000010099 Fagus sylvatica Nutrition 0.000 description 4
- 240000000731 Fagus sylvatica Species 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 241000237852 Mollusca Species 0.000 description 4
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 229920000591 gum Polymers 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 229960004799 tryptophan Drugs 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 3
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 244000003416 Asparagus officinalis Species 0.000 description 3
- 235000005340 Asparagus officinalis Nutrition 0.000 description 3
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 3
- 239000004367 Lipase Substances 0.000 description 3
- 102000004882 Lipase Human genes 0.000 description 3
- 108090001060 Lipase Proteins 0.000 description 3
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000004909 Moisturizer Substances 0.000 description 3
- 229940123973 Oxygen scavenger Drugs 0.000 description 3
- 108090000526 Papain Proteins 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 229930003270 Vitamin B Natural products 0.000 description 3
- PAUSGZCRNOTKPK-UHFFFAOYSA-N [5-hydroxy-6-methyl-4-(octanoyloxymethyl)pyridin-3-yl]methyl octanoate Chemical compound CCCCCCCC(=O)OCC1=CN=C(C)C(O)=C1COC(=O)CCCCCCC PAUSGZCRNOTKPK-UHFFFAOYSA-N 0.000 description 3
- 239000012190 activator Substances 0.000 description 3
- 239000002260 anti-inflammatory agent Substances 0.000 description 3
- 229940121363 anti-inflammatory agent Drugs 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000015278 beef Nutrition 0.000 description 3
- 235000020279 black tea Nutrition 0.000 description 3
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 3
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 235000005487 catechin Nutrition 0.000 description 3
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 229940082500 cetostearyl alcohol Drugs 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 235000013353 coffee beverage Nutrition 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- OZRNSSUDZOLUSN-LBPRGKRZSA-N dihydrofolic acid Chemical compound N=1C=2C(=O)NC(N)=NC=2NCC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OZRNSSUDZOLUSN-LBPRGKRZSA-N 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 235000013373 food additive Nutrition 0.000 description 3
- 239000002778 food additive Substances 0.000 description 3
- 235000015203 fruit juice Nutrition 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 235000009569 green tea Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 235000019421 lipase Nutrition 0.000 description 3
- 239000008308 lipophilic cream Substances 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 230000001333 moisturizer Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 230000003472 neutralizing effect Effects 0.000 description 3
- 235000005152 nicotinamide Nutrition 0.000 description 3
- 239000011570 nicotinamide Substances 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 235000020333 oolong tea Nutrition 0.000 description 3
- 235000019834 papain Nutrition 0.000 description 3
- 229940055729 papain Drugs 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 3
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 3
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 3
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 235000019192 riboflavin Nutrition 0.000 description 3
- 239000002151 riboflavin Substances 0.000 description 3
- 235000015170 shellfish Nutrition 0.000 description 3
- 235000012239 silicon dioxide Nutrition 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- 235000011083 sodium citrates Nutrition 0.000 description 3
- 239000001540 sodium lactate Substances 0.000 description 3
- 235000011088 sodium lactate Nutrition 0.000 description 3
- 229940005581 sodium lactate Drugs 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000014214 soft drink Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- JLIDBLDQVAYHNE-YKALOCIXSA-N (+)-Abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N (Z,Z,Z)-Octadeca-9,12,15-trienoic acid Natural products CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 2
- DXANYXRZRNXGSC-UHFFFAOYSA-N 2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethyl sulfate Chemical compound CC1=C(CCOS([O-])(=O)=O)SC=[N+]1CC1=CN=C(C)N=C1N DXANYXRZRNXGSC-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- QHNVWXUULMZJKD-UHFFFAOYSA-N 3,4-didehydroretinal Chemical compound O=CC=C(C)C=CC=C(C)C=CC1=C(C)C=CCC1(C)C QHNVWXUULMZJKD-UHFFFAOYSA-N 0.000 description 2
- OZRNSSUDZOLUSN-UHFFFAOYSA-N 7,8-Dihydrofolic acid Natural products C1NC=2NC(N)=NC(=O)C=2N=C1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OZRNSSUDZOLUSN-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 244000298715 Actinidia chinensis Species 0.000 description 2
- 235000009434 Actinidia chinensis Nutrition 0.000 description 2
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 241000222336 Ganoderma Species 0.000 description 2
- 239000006000 Garlic extract Substances 0.000 description 2
- 235000011201 Ginkgo Nutrition 0.000 description 2
- 244000194101 Ginkgo biloba Species 0.000 description 2
- 235000008100 Ginkgo biloba Nutrition 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 244000025221 Humulus lupulus Species 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 2
- 235000000069 L-ascorbic acid Nutrition 0.000 description 2
- 108010063045 Lactoferrin Proteins 0.000 description 2
- 102100032241 Lactotransferrin Human genes 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- 229920000161 Locust bean gum Polymers 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 241000736199 Paeonia Species 0.000 description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 235000011034 Rubus glaucus Nutrition 0.000 description 2
- 235000009122 Rubus idaeus Nutrition 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 235000009337 Spinacia oleracea Nutrition 0.000 description 2
- 244000300264 Spinacia oleracea Species 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 241001222097 Xenocypris argentea Species 0.000 description 2
- 244000126002 Ziziphus vulgaris Species 0.000 description 2
- GZQCZDHGTYFJIF-LZWOXQAQSA-N [(2r,3s,4s)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] acetate Chemical compound CC(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=CC(C)=C(C)C=C2N=C2C1=NC(=O)NC2=O GZQCZDHGTYFJIF-LZWOXQAQSA-N 0.000 description 2
- YGJQUAVWZDNGJX-XCTPRCOBSA-H [Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O Chemical compound [Ca++].[Ca++].[Ca++].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O YGJQUAVWZDNGJX-XCTPRCOBSA-H 0.000 description 2
- BLTFCXKOBQLMDR-JDYVBSGKSA-L [K+].[K+].[O-]S([O-])(=O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O Chemical compound [K+].[K+].[O-]S([O-])(=O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O BLTFCXKOBQLMDR-JDYVBSGKSA-L 0.000 description 2
- 125000005037 alkyl phenyl group Chemical group 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 235000013793 astaxanthin Nutrition 0.000 description 2
- 239000001168 astaxanthin Substances 0.000 description 2
- 229940022405 astaxanthin Drugs 0.000 description 2
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 229950004580 benzyl nicotinate Drugs 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 229940073609 bismuth oxychloride Drugs 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- HUHMDPDMDYVOGD-PQYRJTSOSA-L calcium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HUHMDPDMDYVOGD-PQYRJTSOSA-L 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 150000001765 catechin Chemical class 0.000 description 2
- 230000020411 cell activation Effects 0.000 description 2
- 235000016213 coffee Nutrition 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000003544 deproteinization Effects 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- HRUVKSKSDDVGMC-JDYVBSGKSA-L disodium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;sulfate Chemical compound [Na+].[Na+].OS([O-])(=O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] HRUVKSKSDDVGMC-JDYVBSGKSA-L 0.000 description 2
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 229940124274 edetate disodium Drugs 0.000 description 2
- 210000002969 egg yolk Anatomy 0.000 description 2
- 235000013345 egg yolk Nutrition 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 150000002148 esters Chemical group 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- VVIAGPKUTFNRDU-ABLWVSNPSA-N folinic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-ABLWVSNPSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 235000020706 garlic extract Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- 235000021384 green leafy vegetables Nutrition 0.000 description 2
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 2
- 229910000271 hectorite Inorganic materials 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 2
- 229940078795 lactoferrin Drugs 0.000 description 2
- 235000021242 lactoferrin Nutrition 0.000 description 2
- 235000010420 locust bean gum Nutrition 0.000 description 2
- 239000000711 locust bean gum Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- CVNIWQIEKVYHHB-PQYRJTSOSA-L magnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;sulfate Chemical compound [Mg+2].[O-]S([O-])(=O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CVNIWQIEKVYHHB-PQYRJTSOSA-L 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 229960001855 mannitol Drugs 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 235000020124 milk-based beverage Nutrition 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 150000002814 niacins Chemical class 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000007764 o/w emulsion Substances 0.000 description 2
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 2
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 229940067631 phospholipid Drugs 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 235000008160 pyridoxine Nutrition 0.000 description 2
- 150000003227 pyridoxines Chemical class 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 235000020945 retinal Nutrition 0.000 description 2
- 230000002207 retinal effect Effects 0.000 description 2
- 229960003471 retinol Drugs 0.000 description 2
- 235000020944 retinol Nutrition 0.000 description 2
- 239000011607 retinol Substances 0.000 description 2
- 229960000342 retinol acetate Drugs 0.000 description 2
- 235000019173 retinyl acetate Nutrition 0.000 description 2
- 239000011770 retinyl acetate Substances 0.000 description 2
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 2
- 229940108325 retinyl palmitate Drugs 0.000 description 2
- 235000019172 retinyl palmitate Nutrition 0.000 description 2
- 239000011769 retinyl palmitate Substances 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 229940109850 royal jelly Drugs 0.000 description 2
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 2
- 229960001153 serine Drugs 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229940074404 sodium succinate Drugs 0.000 description 2
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000020712 soy bean extract Nutrition 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 229940026510 theanine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 2
- 229960000401 tranexamic acid Drugs 0.000 description 2
- 229940074410 trehalose Drugs 0.000 description 2
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 2
- JBLOGLLUZMBZHM-JBEKKHDOSA-K tripotassium (2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O JBLOGLLUZMBZHM-JBEKKHDOSA-K 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- IRJHMGSFUSXXQJ-JBEKKHDOSA-K trisodium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O IRJHMGSFUSXXQJ-JBEKKHDOSA-K 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- 235000015192 vegetable juice Nutrition 0.000 description 2
- 235000019159 vitamin B9 Nutrition 0.000 description 2
- 239000011727 vitamin B9 Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- CGFPNELNAZZYQL-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;sulfuric acid Chemical compound OS(O)(=O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CGFPNELNAZZYQL-RXSVEWSESA-N 0.000 description 1
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- AVBJHQDHVYGQLS-AWEZNQCLSA-N (2s)-2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-AWEZNQCLSA-N 0.000 description 1
- GYDYJUYZBRGMCC-INIZCTEOSA-N (2s)-2-amino-6-(dodecanoylamino)hexanoic acid Chemical compound CCCCCCCCCCCC(=O)NCCCC[C@H](N)C(O)=O GYDYJUYZBRGMCC-INIZCTEOSA-N 0.000 description 1
- HOMROMWVNDUGRI-RVZXSAGBSA-N (2s)-2-aminopentanedioic acid;(2s)-2,6-diaminohexanoic acid Chemical compound NCCCC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CCC(O)=O HOMROMWVNDUGRI-RVZXSAGBSA-N 0.000 description 1
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
- CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 1
- RUHCWQAFCGVQJX-RVWHZBQESA-N (3s,8s,9s,10r,13r,14s,17r)-3-hydroxy-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-1-one Chemical compound C1C=C2C[C@H](O)CC(=O)[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 RUHCWQAFCGVQJX-RVWHZBQESA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- QYNUQALWYRSVHF-OLZOCXBDSA-N (6R)-5,10-methylenetetrahydrofolic acid Chemical compound C([C@H]1CNC=2N=C(NC(=O)C=2N1C1)N)N1C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 QYNUQALWYRSVHF-OLZOCXBDSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- UYZQWKKNVBJVOF-UHFFFAOYSA-N 1-decoxytetradecane Chemical compound CCCCCCCCCCCCCCOCCCCCCCCCC UYZQWKKNVBJVOF-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- AUFGTPPARQZWDO-YPMHNXCESA-N 10-formyltetrahydrofolic acid Chemical compound C([C@H]1CNC=2N=C(NC(=O)C=2N1)N)N(C=O)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 AUFGTPPARQZWDO-YPMHNXCESA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- AVBJHQDHVYGQLS-UHFFFAOYSA-N 2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)NC(C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-UHFFFAOYSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- KWTQSFXGGICVPE-UHFFFAOYSA-N 2-amino-5-(diaminomethylideneamino)pentanoic acid;hydron;chloride Chemical compound Cl.OC(=O)C(N)CCCN=C(N)N KWTQSFXGGICVPE-UHFFFAOYSA-N 0.000 description 1
- XATHTZNVYDUDGS-UHFFFAOYSA-N 2-octadecylpropane-1,2,3-triol Chemical compound CCCCCCCCCCCCCCCCCCC(O)(CO)CO XATHTZNVYDUDGS-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- YCWUVLPMLLBDCU-STQMWFEESA-N 5-formimidoyltetrahydrofolic acid Chemical compound C([C@H]1CNC=2N=C(NC(=O)C=2N1C=N)N)NC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 YCWUVLPMLLBDCU-STQMWFEESA-N 0.000 description 1
- 229940105150 5-methyltetrahydrofolic acid Drugs 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- MSTNYGQPCMXVAQ-NEPJUHHUSA-N 6R-Tetrahydrofolic acid Chemical compound C([C@@H]1CNC=2N=C(NC(=O)C=2N1)N)NC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 MSTNYGQPCMXVAQ-NEPJUHHUSA-N 0.000 description 1
- VVIAGPKUTFNRDU-UHFFFAOYSA-N 6S-folinic acid Natural products C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241001646648 Aesculus turbinata Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241001237961 Amanita rubescens Species 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- RVEWUBJVAHOGKA-WOYAITHZSA-N Arginine glutamate Chemical compound OC(=O)[C@@H](N)CCC(O)=O.OC(=O)[C@@H](N)CCCNC(N)=N RVEWUBJVAHOGKA-WOYAITHZSA-N 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 229930192334 Auxin Natural products 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 235000011332 Brassica juncea Nutrition 0.000 description 1
- 244000178993 Brassica juncea Species 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 235000011960 Brassica ruvo Nutrition 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 241000219172 Caricaceae Species 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 206010016880 Folate deficiency Diseases 0.000 description 1
- 208000010188 Folic Acid Deficiency Diseases 0.000 description 1
- 241000555712 Forsythia Species 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 229930191978 Gibberellin Natural products 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 240000005074 Hymenocallis caribaea Species 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- MYGVPKMVGSXPCQ-JEDNCBNOSA-N Methylmethionine sulfonium salt Chemical compound [Cl-].C[S+](C)CC[C@H](N)C(O)=O MYGVPKMVGSXPCQ-JEDNCBNOSA-N 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 101100379142 Mus musculus Anxa1 gene Proteins 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 241000183666 Nepsera aquatica Species 0.000 description 1
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 description 1
- 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 244000141353 Prunus domestica Species 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 244000235659 Rubus idaeus Species 0.000 description 1
- XSTYCNWRJAIPMG-UHFFFAOYSA-L S(=O)(=O)([O-])[O-].[Na+].C1(=CC=CC=C1)C=1NC2=C(N1)C=CC=C2.[Na+] Chemical compound S(=O)(=O)([O-])[O-].[Na+].C1(=CC=CC=C1)C=1NC2=C(N1)C=CC=C2.[Na+] XSTYCNWRJAIPMG-UHFFFAOYSA-L 0.000 description 1
- 241001072909 Salvia Species 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- 241001247145 Sebastes goodei Species 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 235000009108 Urtica dioica Nutrition 0.000 description 1
- 244000274883 Urtica dioica Species 0.000 description 1
- 235000010749 Vicia faba Nutrition 0.000 description 1
- 240000006677 Vicia faba Species 0.000 description 1
- 235000002098 Vicia faba var. major Nutrition 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 229930003761 Vitamin B9 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- GLLSGHWYBGERSE-UHFFFAOYSA-N [2-(hydroxymethoxy)phenyl]-phenylmethanone;sodium Chemical compound [Na].OCOC1=CC=CC=C1C(=O)C1=CC=CC=C1 GLLSGHWYBGERSE-UHFFFAOYSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 229940093740 amino acid and derivative Drugs 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 1
- 235000015197 apple juice Nutrition 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 229960004246 arginine glutamate Drugs 0.000 description 1
- 108010013835 arginine glutamate Proteins 0.000 description 1
- 229960003589 arginine hydrochloride Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 239000002363 auxin Substances 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- SHZIWNPUGXLXDT-UHFFFAOYSA-N caproic acid ethyl ester Natural products CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000004106 carminic acid Substances 0.000 description 1
- 235000012730 carminic acid Nutrition 0.000 description 1
- DGQLVPJVXFOQEV-NGOCYOHBSA-N carminic acid Chemical compound OC1=C2C(=O)C=3C(C)=C(C(O)=O)C(O)=CC=3C(=O)C2=C(O)C(O)=C1[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DGQLVPJVXFOQEV-NGOCYOHBSA-N 0.000 description 1
- 229940114118 carminic acid Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000019987 cider Nutrition 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 239000004062 cytokinin Substances 0.000 description 1
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 1
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
- CVOQYKPWIVSMDC-UHFFFAOYSA-L dipotassium;butanedioate Chemical compound [K+].[K+].[O-]C(=O)CCC([O-])=O CVOQYKPWIVSMDC-UHFFFAOYSA-L 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- WPUMTJGUQUYPIV-JIZZDEOASA-L disodium (S)-malate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](O)CC([O-])=O WPUMTJGUQUYPIV-JIZZDEOASA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 229940012466 egg shell membrane Drugs 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229940007062 eucalyptus extract Drugs 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 1
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 description 1
- 239000011714 flavin adenine dinucleotide Substances 0.000 description 1
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 235000008191 folinic acid Nutrition 0.000 description 1
- 239000011672 folinic acid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- IXORZMNAPKEEDV-UHFFFAOYSA-N gibberellic acid GA3 Natural products OC(=O)C1C2(C3)CC(=C)C3(O)CCC2C2(C=CC3O)C1C3(C)C(=O)O2 IXORZMNAPKEEDV-UHFFFAOYSA-N 0.000 description 1
- 239000003448 gibberellin Substances 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229940038487 grape extract Drugs 0.000 description 1
- 235000015201 grapefruit juice Nutrition 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 235000020717 hawthorn extract Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- 229940005740 hexametaphosphate Drugs 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 235000020721 horse chestnut extract Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 description 1
- 229960001669 kinetin Drugs 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940058690 lanosterol Drugs 0.000 description 1
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 229960001691 leucovorin Drugs 0.000 description 1
- ZNOVTXRBGFNYRX-ABLWVSNPSA-N levomefolic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 ZNOVTXRBGFNYRX-ABLWVSNPSA-N 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229960005337 lysine hydrochloride Drugs 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229940057948 magnesium stearate Drugs 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 150000004701 malic acid derivatives Chemical class 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- AHXDSVSZEZHDLV-UHFFFAOYSA-N mesulfen Chemical compound CC1=CC=C2SC3=CC(C)=CC=C3SC2=C1 AHXDSVSZEZHDLV-UHFFFAOYSA-N 0.000 description 1
- 229960005479 mesulfen Drugs 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- XONPDZSGENTBNJ-UHFFFAOYSA-N molecular hydrogen;sodium Chemical compound [Na].[H][H] XONPDZSGENTBNJ-UHFFFAOYSA-N 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 210000000276 neural tube Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 150000006636 nicotinic acid Chemical class 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- UVPGECJLXBGLDW-UHFFFAOYSA-N octadecan-7-ol Chemical compound CCCCCCCCCCCC(O)CCCCCC UVPGECJLXBGLDW-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 235000015205 orange juice Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000010330 ougon Substances 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229940116257 pepper extract Drugs 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229950004354 phosphorylcholine Drugs 0.000 description 1
- PYJNAPOPMIJKJZ-UHFFFAOYSA-N phosphorylcholine chloride Chemical compound [Cl-].C[N+](C)(C)CCOP(O)(O)=O PYJNAPOPMIJKJZ-UHFFFAOYSA-N 0.000 description 1
- 230000000176 photostabilization Effects 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000003375 plant hormone Substances 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- PHZLMBHDXVLRIX-UHFFFAOYSA-M potassium lactate Chemical compound [K+].CC(O)C([O-])=O PHZLMBHDXVLRIX-UHFFFAOYSA-M 0.000 description 1
- 239000001521 potassium lactate Substances 0.000 description 1
- 235000011085 potassium lactate Nutrition 0.000 description 1
- 229960001304 potassium lactate Drugs 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 229940056692 resinol Drugs 0.000 description 1
- 150000003726 retinal derivatives Chemical class 0.000 description 1
- 150000003287 riboflavins Chemical class 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 235000019992 sake Nutrition 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 235000019265 sodium DL-malate Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960001790 sodium citrate Drugs 0.000 description 1
- 229940037001 sodium edetate Drugs 0.000 description 1
- 239000001394 sodium malate Substances 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- KJCLYACXIWMFCC-UHFFFAOYSA-M sodium;5-benzoyl-4-hydroxy-2-methoxybenzenesulfonate Chemical compound [Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 KJCLYACXIWMFCC-UHFFFAOYSA-M 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 235000015040 sparkling wine Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical class NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 150000003544 thiamines Chemical class 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 229910000404 tripotassium phosphate Inorganic materials 0.000 description 1
- 235000019798 tripotassium phosphate Nutrition 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 239000009538 yokuinin Substances 0.000 description 1
- 229940098697 zinc laurate Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- ZNVKGUVDRSSWHV-UHFFFAOYSA-L zinc;4-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=C(S([O-])(=O)=O)C=C1.OC1=CC=C(S([O-])(=O)=O)C=C1 ZNVKGUVDRSSWHV-UHFFFAOYSA-L 0.000 description 1
- GPYYEEJOMCKTPR-UHFFFAOYSA-L zinc;dodecanoate Chemical compound [Zn+2].CCCCCCCCCCCC([O-])=O.CCCCCCCCCCCC([O-])=O GPYYEEJOMCKTPR-UHFFFAOYSA-L 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Description
本発明は、光等に対して安定な葉酸含有組成物、及び葉酸の安定化方法に関し、特に皮膚外用剤又は化粧料として有用なものである。 The present invention relates to a folic acid-containing composition that is stable to light and the like, and a method for stabilizing folic acid, and is particularly useful as an external preparation for skin or a cosmetic.
葉酸はビタミンM、ビタミンB9、プテロイルグルタミン酸とも呼ばれ、アミノ酸やタンパク質、赤血球や核酸の合成などに関与する、生体にとって必要不可欠な栄養素である。葉酸は人体においてde novo合成されないため、食事等によって摂取する必要がある。葉酸の効果について近年特に注目されているのは、母体の妊娠時の葉酸欠乏により、神経管異常の新生児が生まれる確率が増えるが、葉酸の投与によりこれを予防できることである(非特許文献1)。また、葉酸がガン、特に上皮性のガンに対して防御作用を示すとする報告もなされており(非特許文献2)、葉酸の重要性が再認識されつつある。そのため、厚生労働省では一般成人で240μg/日、妊婦で440μg/日の葉酸を摂取することを推奨している。葉酸はほうれん草等の野菜や果物に多く含まれているが、その含有量は1日の必要量に対しては低いものであり、必要とされる葉酸全てを食事から摂取することは難しいことが多い。したがって、葉酸を配合した栄養補助食品等が開発され、特に妊娠中の女性にはサプリメントが汎用されている。 Folic acid is also called vitamin M, vitamin B9, and pteroylglutamic acid, and is an essential nutrient for living bodies involved in the synthesis of amino acids, proteins, erythrocytes and nucleic acids. Since folic acid is not synthesized de novo in the human body, it must be taken with food. In recent years, attention has been particularly focused on the effect of folic acid, although the probability of a newborn with a neural tube abnormality being born increases due to folic acid deficiency during pregnancy of the mother, but this can be prevented by administration of folic acid (Non-patent Document 1). . In addition, it has been reported that folic acid has a protective action against cancer, particularly epithelial cancer (Non-patent Document 2), and the importance of folic acid is being recognized again. For this reason, the Ministry of Health, Labor and Welfare recommends taking folic acid at 240 μg / day for general adults and 440 μg / day for pregnant women. Folic acid is abundant in vegetables and fruits such as spinach, but its content is low compared to the daily requirement, and it is difficult to get all the necessary folic acid from the diet. Many. Therefore, dietary supplements containing folic acid have been developed, and supplements are widely used especially for pregnant women.
一方、葉酸は皮膚においては、損傷を受けたDNAを修復する効果を有し、特に紫外線によって引き起こされるDNA損傷を予防・修復するために有効であることが報告されている。(特許文献1)。また、還元型葉酸である7,8−ジヒドロ葉酸はメラノサイト表面上のc−kitレセプターに対するSCFの結合を特異的に阻害し、メラニンの過剰生成に伴う皮膚の褐色化やシミ・ソバカスの発生の予防又は改善効果を有することが報告されている(特許文献2)。 On the other hand, it has been reported that folic acid has an effect of repairing damaged DNA in the skin, and is particularly effective for preventing and repairing DNA damage caused by ultraviolet rays. (Patent Document 1). In addition, 7,8-dihydrofolic acid, which is a reduced folic acid, specifically inhibits the binding of SCF to the c-kit receptor on the melanocyte surface, causing browning of the skin and generation of spots and freckles associated with excessive production of melanin. It has been reported to have a preventive or ameliorating effect (Patent Document 2).
上述のとおり、様々な疾病や現象の予防や治療、健康の維持に葉酸が有用であることが報告され、近年、葉酸を摂取、外用等する必要性・重要性が益々高まっているが、葉酸は不安定な化合物であり、葉酸を配合した組成物、特に水性組成物の安定性を確保するのは非常に困難である。
葉酸が安定に存在し得るのは弱酸性から中性領域の限られた領域である。また、葉酸は光や熱によっても容易に分解する(非特許文献3)ので、冷暗所において適切に保存しなければ組成物中の葉酸含有量は経時的に低下し、変色や沈殿を生じてしまう。そのため、葉酸を配合した飲料や点滴剤、化粧料等、特にPETボトル等の遮光性の低い容器を適用した場合や、組成物が商品として店頭陳列され強い光にさらされた場合等には保存安定性に大きな問題があった。
As described above, it has been reported that folic acid is useful for the prevention and treatment of various diseases and phenomena, and maintenance of health. In recent years, the necessity and importance of folic acid ingestion and topical use has been increasing. Is an unstable compound, and it is very difficult to ensure the stability of a composition containing folic acid, particularly an aqueous composition.
Folic acid can exist stably in a limited region from weakly acidic to neutral region. In addition, since folic acid is easily decomposed by light and heat (Non-patent Document 3), the content of folic acid in the composition decreases with time, resulting in discoloration and precipitation unless properly stored in a cool and dark place. . Therefore, preserved when folic acid-containing beverages, drops, cosmetics, etc., especially containers with low light shielding properties such as PET bottles are applied, or when the composition is displayed over the counter and exposed to strong light as a product. There was a big problem with stability.
これを克服するにあたり、従来は、葉酸をトレハロースやエリスリトールと併用することで水に溶解させやすくし、熱安定性を向上させる手法が報告されていた。しかし、葉酸配合量が極端に少なく(0.00007%程度)、葉酸の有用性を発揮させるためには十分な量ではなかった。また、安定化剤として糖類が配合されるため、飲食物として使用した場合には甘味を生じてしまう点、皮膚外用剤として使用した場合には使用性が悪い(感触がべたつく)点において満足のいくものではなかった(特許文献3)。 In order to overcome this, conventionally, a method has been reported in which folic acid is used in combination with trehalose or erythritol to facilitate dissolution in water and to improve thermal stability. However, the blending amount of folic acid is extremely small (about 0.00007%), and it is not a sufficient amount for exhibiting the usefulness of folic acid. In addition, since saccharides are blended as a stabilizer, sweetness is produced when used as a food and drink, and satisfactory in terms of poor usability (stickiness) when used as a skin external preparation. It did not go (Patent Document 3).
また、特定のpH領域内において、葉酸と多種多量のアミノ酸とを併用配合することにより、多種のアミノ酸が相互補完することで熱安定性を保つ手法(特許文献4)も報告されている。しかし、安定化剤として配合されたアミノ酸の量が非常に多い(10%程度)ため、熱や光により変臭を生じやすい点、飲食物として使用した場合には特有の風味や味を生じる点、皮膚外用剤として使用した場合には使用性が悪い(感触がべたつく)点において好ましい方法ではなかった。 In addition, there has also been reported a technique (Patent Document 4) that maintains thermal stability by combining folic acid and a large amount of a large amount of amino acids in a specific pH region so that the various amino acids complement each other. However, since the amount of amino acid blended as a stabilizer is very large (about 10%), it is likely to generate a strange odor due to heat and light, and when it is used as a food or drink, it has a unique flavor and taste. When used as an external preparation for skin, it was not a preferable method in terms of poor usability (feeling sticky).
また、葉酸の光安定性を高める方法としては、カテキン類やポリフェノールを配合する方法が報告されている。しかし、飲食物として使用した場合には特定の風味や味を生じる点、皮膚外用剤としてとして使用した場合にはカテキン類やポリフェノールの感作性など安全性面に問題がある点において満足のいくものではなかった(特許文献5、6)。
すなわち、これらの葉酸の安定化方法は、葉酸の安定化という目的は達成されるものの、官能(風味・味・感触等)・安全性の観点からは安定化剤による弊害が大きいものであった。したがって、葉酸の安定化という目的は達成しつつ、官能(風味・味・感触等)・安全性に与える影響が小さい安定化方法が求められていた。
In addition, as a method for enhancing the photostability of folic acid, a method of blending catechins or polyphenols has been reported. However, it is satisfactory in that it produces a specific flavor and taste when used as a food and drink, and has problems in terms of safety such as sensitization of catechins and polyphenols when used as a skin external preparation. It was not a thing (patent documents 5, 6).
In other words, these methods for stabilizing folic acid, although the purpose of stabilizing folic acid is achieved, are seriously harmful to the stabilizer from the viewpoint of functionality (flavor, taste, feel, etc.) and safety. . Accordingly, there has been a demand for a stabilization method that achieves the objective of stabilizing folic acid and has a small effect on the sensory (flavor, taste, feel, etc.) and safety.
本発明は、官能(風味・味・感触等)・安全性を損ねず、葉酸の劣化を抑制するための方法を提供するものである。また、葉酸の安定性を高めた組成物を提供するものである。 The present invention provides a method for suppressing deterioration of folic acid without impairing sensory (flavor, taste, touch, etc.) and safety. Moreover, the composition which improved stability of folic acid is provided.
本発明者は上記課題を解決すべく鋭意研究を重ねた結果、特定のアミノ酸を配合することで、葉酸が溶解した組成物の光に対する安定性を向上させることができることを見出した。また、これらに特定の水溶性高分子を併用することで、更に安定性が向上することを見出し、本発明を完成するに至った。
すなわち、本発明は以下の通りである。
(1)次の成分(A)及び(B);
(A)葉酸
(B)リジン、アルギニン、トリプトファン、ヒドロキプロリン及びこれらの塩から選ばれる1種以上を配合することを特徴とする葉酸含有組成物。
(2)さらに成分(C)リン酸、クエン酸、コハク酸、乳酸及びこれらの塩から選ばれる1種以上を配合することを特徴とする(1)記載の葉酸含有組成物。
(3)前記(A)と(B)の配合質量比が5:1〜1:5であることを特徴とする(1)又は(2)に記載の葉酸含有組成物。
(4)さらに成分(D)カルボキシビニルポリマー及び/又はアルキル変性カルボキシビニルポリマーを配合することを特徴とする(1)〜(3)いずれかに記載の葉酸含有組成物。
(5)前記組成物が皮膚外用剤又は化粧料であることを特徴とする(1)〜(4)いずれかに記載の葉酸含有組成物。
(6)リジン、アルギニン、トリプトファン、ヒドロキプロリン及びこれらの塩から選ばれる1種以上を配合することを特徴とする葉酸の安定化方法。
(7)さらに成分(C)リン酸、クエン酸、コハク酸、乳酸及びこれらの塩から選ばれる1種以上を配合することを特徴とする(6)記載の葉酸の安定化方法。
(8)前記(A)と(B)の配合質量比が5:1〜1:5であることを特徴とする(6)又は(7)に記載の葉酸の安定化方法。
As a result of intensive studies to solve the above problems, the present inventor has found that the stability to light of a composition in which folic acid is dissolved can be improved by adding a specific amino acid. Moreover, it discovered that stability was further improved by using specific water-soluble polymer together with these, and came to complete this invention.
That is, the present invention is as follows.
(1) the following components (A) and (B);
(A) Folic acid (B) A folic acid-containing composition comprising at least one selected from lysine, arginine, tryptophan, hydroxyproline, and salts thereof.
(2) The folic acid-containing composition according to (1), further comprising at least one component selected from component (C) phosphoric acid, citric acid, succinic acid, lactic acid and salts thereof.
(3) The folic acid-containing composition according to (1) or (2), wherein the blending mass ratio of (A) and (B) is 5: 1 to 1: 5.
(4) The folic acid-containing composition according to any one of (1) to (3), further comprising a component (D) carboxyvinyl polymer and / or an alkyl-modified carboxyvinyl polymer.
(5) The folic acid-containing composition according to any one of (1) to (4), wherein the composition is an external preparation for skin or a cosmetic.
(6) A method for stabilizing folic acid, comprising blending at least one selected from lysine, arginine, tryptophan, hydroxyproline, and salts thereof.
(7) The method for stabilizing folic acid according to (6), further comprising at least one component selected from component (C) phosphoric acid, citric acid, succinic acid, lactic acid and salts thereof.
(8) The method for stabilizing folic acid according to (6) or (7), wherein the blending mass ratio of (A) and (B) is from 5: 1 to 1: 5.
本発明は、特定のアミノ酸を安定化剤として配合したことにより、葉酸を安定化したものである。本発明は、葉酸の光による劣化を防止し、経時での外観変化や変臭が生じない。また、皮膚外用剤としての感触も良く、安全性も高い。さらに、特定の水溶性高分子を配合することにより、より葉酸が安定化される。 In the present invention, folic acid is stabilized by blending a specific amino acid as a stabilizer. The present invention prevents folic acid from being deteriorated by light and does not cause changes in appearance or odor over time. In addition, it feels good as an external preparation for skin and has high safety. Furthermore, folic acid is further stabilized by blending a specific water-soluble polymer.
以下に、本発明の実施の態様について説明する。なお、本明細書において、「〜」はその前後の数値を含む範囲を意味するものとする。 Hereinafter, embodiments of the present invention will be described. In the present specification, “to” means a range including numerical values before and after.
本発明の成分(A)の葉酸は、葉酸(プテロイルモノグルタミン酸)、テトラヒドロ葉酸、ジヒドロ葉酸、5位及び/又は10位が置換された置換テトラヒドロ葉酸、及び重合型のリグルタミル葉酸(2から8のグルタミン酸残基を有する)を意味する。具体例としては、葉酸(プロテイルモノグルタミン酸)、7,8−ジヒドロ葉酸、5,6,7,8−テトラヒドロ葉酸、5−メチルテトラヒドロ葉酸、5,10−メチレンテトラヒドロ葉酸、5,10−メテニルテトラヒドロ葉酸、5,10−ホルムイミノテトラヒドロ葉酸、5−ホルミルテトラヒドロ葉酸(ロイコボリン)、5−ホルミルイミノテトラヒドロ葉酸、10−ホルミルテトラヒドロ葉酸、重合型のポリグルタミル葉酸(2から8のグルタミン酸残基を有する)、それらのエステル体、及びそれらの塩、それらの混合物を挙げることができる。重合型のポリグルタミル葉酸としては、例えば、5−ホルムイミノ−(6S)−テトラヒドロ葉酸等のテトラヒドロ葉酸のジグルタミル、トリグルタミル、テトラグルタミル、ペンタグルタミルおよびヘキサグルタミル誘導体等を挙げることができる。また、特に限定のない限り、用語「葉酸」は、両方のエナンチオマー(αS)および(αR)を包含し、そしてテトラヒドロ葉酸については、そのジアステレオマー((6S,αS)、(6S,αR)、(6R,αS)および(6R,αR))を包含する。
プロテイルモノグルタミン酸は、日本薬局方又は食品添加物規格に収載された「葉酸」に相当する合成品がBASF武田ビタミン株式会社及びディー・エス・エムジャパン株式会社等から入手できる。また、食物由来の場合は、緑茶、烏龍茶、紅茶等の茶類、大豆、ソラマメ等の豆類、からし菜、ほうれん草、みずかけ菜、なば菜、グリーンアスパラガス、春菊、サツマイモ、ブロッコリー、チンゲン菜等の野菜、いちご、パパイヤ、オレンジ、ミカン等の果物類から定法に従って抽出したものが使用可能である。これら植物からの葉酸抽出は、茶葉の場合は、温水乃至熱湯で抽出することによって、豆類、野菜類、果物類の場合は、搾汁液から不溶性画分を除き、抽出液を回収することによって達成される。
本発明の成分(A)としては、光に対する安定性が高いこと及び生体内での利用率が高いことから、合成品のプロテイルモノグルタミン酸が最も好ましい。
The folic acid of the component (A) of the present invention includes folic acid (pteroyl monoglutamic acid), tetrahydrofolic acid, dihydrofolic acid, substituted tetrahydrofolic acid substituted at the 5-position and / or the 10-position, and polymerized liglutamyl folic acid (2 to 8). Having a glutamic acid residue). Specific examples include folic acid (protail monoglutamic acid), 7,8-dihydrofolic acid, 5,6,7,8-tetrahydrofolic acid, 5-methyltetrahydrofolic acid, 5,10-methylenetetrahydrofolic acid, 5,10-me Tenenyltetrahydrofolic acid, 5,10-formiminotetrahydrofolic acid, 5-formyltetrahydrofolic acid (leucovorin), 5-formyliminotetrahydrofolic acid, 10-formyltetrahydrofolic acid, polymerized polyglutamylfolic acid (from 2 to 8 glutamic acid residues ), Ester forms thereof, salts thereof, and mixtures thereof. Examples of the polymerized polyglutamyl folic acid include dihydrotayl, triglutamyl, tetraglutamyl, pentaglutamyl and hexaglutamyl derivatives of tetrahydrofolic acid such as 5-formimino- (6S) -tetrahydrofolic acid. Also, unless otherwise limited, the term “folic acid” encompasses both enantiomers (αS) and (αR), and for tetrahydrofolic acid, its diastereomers ((6S, αS), (6S, αR) , (6R, αS) and (6R, αR)).
As for protail monoglutamic acid, a synthetic product corresponding to “folic acid” listed in the Japanese Pharmacopoeia or food additive standards can be obtained from BASF Takeda Vitamin Co., Ltd., DSM Japan Co., Ltd. and the like. In the case of food origin, teas such as green tea, oolong tea, black tea, beans such as soybeans and broad beans, mustard greens, spinach, mizukake greens, nabara greens, green asparagus, spring chrysanthemum, sweet potatoes, broccoli, tinning What was extracted from fruits, such as vegetables, such as vegetables, strawberries, papayas, oranges, mandarin oranges according to a usual method, can be used. Extraction of folic acid from these plants is achieved by extracting with hot water or hot water in the case of tea leaves, and in the case of beans, vegetables and fruits, removing the insoluble fraction from the juice and collecting the extract. Is done.
As the component (A) of the present invention, synthetic proteyl monoglutamic acid is most preferable because of its high stability to light and high utilization in vivo.
本発明の(A)の配合量は0.00001〜1質量%(以下、「%」と略記する)が好ましく、0.0001〜0.5%がより好ましく、0.01〜0.2%が特に好ましい。この範囲であると、葉酸の有用性をより効果的に発揮させながら、葉酸の安定化をはかることができる。 The blending amount of (A) of the present invention is preferably 0.00001 to 1% by mass (hereinafter abbreviated as “%”), more preferably 0.0001 to 0.5%, and 0.01 to 0.2%. Is particularly preferred. Within this range, it is possible to stabilize folic acid while more effectively using folic acid.
本発明の成分(B)のアミノ酸とは、リジン、アルギニン、トリプトファン、ヒドロキシプロリン及びこれらの塩から選ばれるものであり、これら1種以上を配合することを必要とする。本発明の成分(B)のリジン、アルギニン、トリプトファン、ヒドロキシプロリン及びこれらの塩は、成分(A)の安定化剤として用いられるものであり、製造方法等は特に限定されるものではない。
アミノ酸の塩としてはリジン塩酸塩、リジングルタミン酸塩、アルギニン塩酸塩、アルギニングルタミン酸塩等があげられる。
本発明においては、匂い変化が少ない点から成分(B)としてL−リジン、L−リジン塩酸塩、L−アルギニン、又はL−アルギニン塩酸塩を用いることが好ましく、L−リジン、L−リジン塩酸塩が特に好ましい。
The amino acid of the component (B) of the present invention is selected from lysine, arginine, tryptophan, hydroxyproline and salts thereof, and it is necessary to add one or more of these. The lysine, arginine, tryptophan, hydroxyproline and salts thereof of the component (B) of the present invention are used as the stabilizer of the component (A), and the production method and the like are not particularly limited.
Examples of amino acid salts include lysine hydrochloride, lysine glutamate, arginine hydrochloride, and arginine glutamate.
In the present invention, it is preferable to use L-lysine, L-lysine hydrochloride, L-arginine, or L-arginine hydrochloride as the component (B) from the viewpoint of little odor change, and L-lysine, L-lysine hydrochloride A salt is particularly preferred.
本発明の(B)の配合量は、(A)の配合量に基づいて適宜決定することができるが、0.001〜5%が好ましく、0.05〜1%がより好ましく、0.1〜0.5%が特に好ましい。この範囲であると葉酸を十分に安定化し、変臭のなさや使用性(感触)の点でより好ましいものとすることができる。 Although the compounding quantity of (B) of this invention can be suitably determined based on the compounding quantity of (A), 0.001 to 5% is preferable, 0.05 to 1% is more preferable, 0.1 -0.5% is particularly preferred. Within this range, folic acid can be sufficiently stabilized, and more favorable in terms of no odor change and usability (feel).
本発明の(A)と(B)の配合質量比は、1:10〜10:1が好ましく、皮膚外用剤としての使用性(感触)の観点から1:5〜5:1がさらに好ましく、匂いの観点から1:2〜2:1が特に好ましい。 The blending mass ratio of (A) and (B) of the present invention is preferably 1:10 to 10: 1, more preferably 1: 5 to 5: 1 from the viewpoint of usability (feel) as a skin external preparation, From the viewpoint of odor, 1: 2 to 2: 1 is particularly preferable.
本発明で用いられる成分(C)は、葉酸の溶解性の観点からpHを6以上とする為の緩衝剤であり、リン酸、クエン酸、コハク酸、乳酸及びこれらの塩から選ばれる1種以上を配合することを必要とする。これらの塩の好ましい例としては、リン酸一水素二ナトリウム、リン酸二水素ナトリウム、リン酸三ナトリウム、クエン酸ナトリウム、コハク酸ナトリウム、乳酸ナトリウム、リン酸一水素二カリウム、リン酸二水素カリウム、リン酸三カリウム、クエン酸カリウム、コハク酸カリウム、乳酸カリウム等が挙げられる。葉酸安定化の観点から、本発明の成分(C)はクエン酸/クエン酸塩、乳酸/乳酸塩またはリン酸塩/リン酸塩の組み合わせとするのが好ましく、リン酸一水素二ナトリウム/リン酸二水素ナトリウムを組み合わせて用いるのが特に好ましい。 Component (C) used in the present invention is a buffer for adjusting the pH to 6 or more from the viewpoint of solubility of folic acid, and one kind selected from phosphoric acid, citric acid, succinic acid, lactic acid, and salts thereof. It is necessary to blend the above. Preferred examples of these salts include disodium monohydrogen phosphate, sodium dihydrogen phosphate, trisodium phosphate, sodium citrate, sodium succinate, sodium lactate, dipotassium monohydrogen phosphate, potassium dihydrogen phosphate. , Tripotassium phosphate, potassium citrate, potassium succinate, potassium lactate and the like. From the viewpoint of folic acid stabilization, the component (C) of the present invention is preferably a combination of citric acid / citrate, lactic acid / lactate or phosphate / phosphate, and disodium monohydrogen phosphate / phosphorus It is particularly preferable to use sodium dihydrogen acid in combination.
本発明の(C)の配合量は、用いる緩衝剤の種類、併用されるアミノ酸の種類や配合量によって適宜選択されるが、通常は0.001〜5%、好ましくは0.005〜3質量%、より好ましくは0.01〜2質量%である。特に、組成物全体のpHを好ましくは6.0以上、より好ましくは6.5以上にする配合量とするのが好ましい。 The blending amount of (C) of the present invention is appropriately selected depending on the type of buffering agent used, the type of amino acid used and the blending amount, and is usually 0.001 to 5%, preferably 0.005 to 3 mass. %, More preferably 0.01 to 2% by mass. In particular, the blending amount is preferably such that the pH of the entire composition is preferably 6.0 or more, more preferably 6.5 or more.
本発明の成分(D)のカルボキシビニルポリマーは、アクリル酸の共重合体であり、医薬部外品原料規格収載の「カルボキシビニルポリマー」に相当するものである。本発明の成分(D)のアルキル変性カルボキシビニルポリマーは、及びアクリル酸の共重合体にアルキル鎖を付加したものであり、医薬部外品原料規格収載の「アクリル酸・メタクリル酸アルキル共重合体」に相当するものである。これらの市販品としては、カーボポール940、941、934、980、1342、ペミュレンTR−1、TR−2(全て、GooodrichChemical社製)等が挙げられる。本発明の成分(D)のカルボキシビニルポリマー又はアルキル変性カルボキシビニルポリマーは成分(A)〜(C)に加えて配合することにより、葉酸の安定性がさらに向上するものである。これはカルボキシビニルポリマー又はアルキル変性カルボキシビニルポリマーのカルボキシル基と葉酸が相互作用することによると考えられる。葉酸安定化の観点から、本発明の成分(D)としてはアルキル変性カルボキシビニルポリマーが好ましい。また、成分(D)は中和剤により中和して用いることがより好ましく、中和剤としては水酸化ナトリウム、水酸化カリウムが好適に用いられ、成分(B)のリジン、アルギニン又はこれらの塩を中和剤として用いることもできる。 The carboxyvinyl polymer of component (D) of the present invention is a copolymer of acrylic acid and corresponds to the “carboxyvinyl polymer” listed in the quasi-drug raw material standard. The alkyl-modified carboxyvinyl polymer of component (D) of the present invention is a copolymer of acrylic acid and an alkyl chain added thereto, and “acrylic acid / alkyl methacrylate copolymer” listed in the quasi-drug raw material standard. Is equivalent to. Examples of these commercially available products include Carbopol 940, 941, 934, 980, 1342, Pemulen TR-1, TR-2 (all manufactured by Goodrich Chemical). By adding the component (D) carboxyvinyl polymer or alkyl-modified carboxyvinyl polymer of the present invention in addition to the components (A) to (C), the stability of folic acid is further improved. This is considered to be due to the interaction between the carboxyl group of the carboxyvinyl polymer or the alkyl-modified carboxyvinyl polymer and folic acid. From the viewpoint of stabilizing folic acid, the component (D) of the present invention is preferably an alkyl-modified carboxyvinyl polymer. The component (D) is more preferably neutralized with a neutralizing agent, and sodium hydroxide and potassium hydroxide are preferably used as the neutralizing agent. The component (B) lysine, arginine or these A salt can also be used as a neutralizing agent.
本発明の(D)の配合量は、葉酸の配合量、併用されるアミノ酸の種類や配合量によって適宜選択されるが、通常は0.001〜1%、好ましくは0.005〜0.5質量%、より好ましくは0.01〜0.2質量%である。この範囲であると、葉酸の安定化効果が十分であるだけではなく、べたつきを生じず、使用性(感触)の点でより好ましいものを得ることができる。 The blending amount of (D) of the present invention is appropriately selected depending on the blending amount of folic acid, the type and blending amount of amino acids used in combination, and is usually 0.001 to 1%, preferably 0.005 to 0.5. It is 0.01 mass%, More preferably, it is 0.01-0.2 mass%. Within this range, not only the stabilizing effect of folic acid is sufficient, but stickiness does not occur, and a more preferable one in terms of usability (feel) can be obtained.
本発明における「安定化」とは、葉酸が分解、劣化されることを抑制し、含量、外観及び匂いの変化を抑制することをいう。光に対する安定化であれば30℃、8,000ルクスの蛍光灯(人工気象器)の光の下に置いた場合に、少しでも葉酸に対する安定化効果が見出せることを意味し、好ましくは、当該条件下に3日置いた場合に外観(濁度、沈殿、変色)又は匂いの変化が生じないこと、特に好ましくは当該条件下に2週間置いた場合に外観(濁度、沈殿、変色)又は匂いの変化が生じないことを意味する。また、熱に対する安定化であれば40℃で1ヶ月以上保存した場合に、少しでも葉酸に対する安定化効果が見出せることを意味し、その際に葉酸の残存率を90%以上、好ましくは95%以上、さらに好ましくは98%以上に保つことを意味する。 “Stabilization” in the present invention refers to inhibiting folic acid from being decomposed and degraded, and inhibiting changes in content, appearance, and odor. If it is stabilized against light, it means that even if it is placed under the light of a fluorescent lamp (artificial meteor) at 30 ° C. and 8,000 lux, a stabilizing effect against folic acid can be found even slightly. No change in appearance (turbidity, precipitation, discoloration) or odor when placed under conditions for 3 days, particularly preferably appearance (turbidity, precipitation, discoloration) or It means no change in odor. In addition, if it is stabilized against heat, it means that even if it is stored at 40 ° C. for 1 month or more, a stabilizing effect against folic acid can be found, and at that time, the residual ratio of folic acid is 90% or more, preferably 95%. As mentioned above, it means keeping at 98% or more.
本発明の葉酸含有組成物、特に皮膚外用剤又は化粧料は、遮光条件下での保管を組み合わせることにより、さらに葉酸安定化効果を高めることができる。遮光条件下での保管とは、遮光された箱等に透明または不透明の容器に入れた当該皮膚外用剤又は化粧料の保管、および遮光性の容器に当該皮膚外用剤又は化粧料を入れた保管など、皮膚外用剤又は化粧料そのものに直接光を当てないような保管をいう。ここで、遮光条件とは、可視光の約50%以上、好ましくは約70%以上、より好ましくは約90%以上がカットされる状態をいう。また、特に波長の短い光はエネルギーが高いため、波長約340nm以下の光が約80%以上、より好ましくは約90%以上カットされる状態が望ましい。 The folic acid-containing composition of the present invention, particularly a skin external preparation or cosmetic, can further enhance the folic acid stabilization effect by combining storage under light-shielding conditions. Storage under light-shielding conditions means storage of the external preparation for skin or cosmetics in a transparent or opaque container in a light-shielded box, etc., and storage of the external preparation for skin or cosmetics in a light-shielding container This means storage that does not directly expose the skin external preparation or the cosmetic itself. Here, the light shielding condition refers to a state in which about 50% or more, preferably about 70% or more, more preferably about 90% or more of visible light is cut. In particular, since light with a short wavelength has high energy, it is desirable that light having a wavelength of about 340 nm or less be cut by about 80% or more, more preferably about 90% or more.
本発明の「安定化された葉酸含有組成物」とは、葉酸が安定化された状態で存在し得る葉酸含有組成物を意味し、形態的には、皮膚外用剤等に添加するための葉酸及びアミノ酸を含有してなる配合用原体としての組成物、これら配合用原体を皮膚外用剤等原液に加えてなる皮膚外用剤等の組成物として存在し得る。前記組成物の性状は、特に限定されず、液状、ペースト状、ゲル状、固形状、粉末状等の何れの性状でもよい。用途面から見た場合、前記組成物は、外用、内服、経口摂取、注射又は点滴するための医薬組成物、医薬部外品組成物、輸液;皮膚外用剤、化粧料(医薬部外品を含む);食品添加物、飲料組成物、又は食品組成物(栄養機能食品、特定保健用食品、機能性食品、健康食品、サプリメント)等に区分することができる。本発明の安定化された葉酸含有組成物は、葉酸安定化剤の配合量が少なくても十分な効果を発揮するため、味・感触等が重要な品質の一つである飲料組成物若しくは食品組成物、又は皮膚外用剤若しくは化粧料とするのが好ましい。また、皮膚に適用した際にべたつきがなく、使用性(感触)が良好なものであるため、皮膚外用剤又は化粧料とするのが特に好ましい。 The “stabilized folic acid-containing composition” of the present invention means a folic acid-containing composition that can exist in a stabilized state, and in form, folic acid for addition to a skin external preparation or the like. And an amino acid-containing composition as a raw material for blending, and a composition such as a skin external preparation obtained by adding these raw materials for blending to a stock solution such as a skin external preparation. The property of the composition is not particularly limited, and may be any property such as liquid, paste, gel, solid, and powder. From the viewpoint of use, the composition can be used for external use, internal use, oral intake, injection or infusion, pharmaceutical composition, quasi-drug composition, infusion; skin external preparation, cosmetic (a quasi-drug). A food additive, a beverage composition, or a food composition (nutrient functional food, food for specified health use, functional food, health food, supplement), and the like. The stabilized folic acid-containing composition of the present invention exhibits a sufficient effect even if the blending amount of the folic acid stabilizer is small, so that the beverage composition or food is one of the important qualities such as taste and feel. A composition, or an external preparation for skin or a cosmetic is preferred. Moreover, since it is not sticky when applied to the skin and has good usability (feel), it is particularly preferable to use it as a skin external preparation or cosmetic.
飲料組成物は、配合形態の例としては、特に限定されず、例えば、緑茶、ウーロン茶、紅茶等の茶飲料;リンゴジュース、グレープフルーツジュース、オレンジジュース等のジュース類;果汁配合飲料;野菜汁配合飲料;コーヒー飲料;ココア飲料;牛乳等の乳飲料;コーラ、サイダー等の炭酸飲料;スポーツ飲料;豆乳;ミネラルウォーター;ニアウォーター飲料;ダイエットサポート飲料;栄養補給飲料等である。また、ビール、発泡酒、ワイン、日本酒等のアルコール飲料であってもよい。食品組成物は、上記配合用組成物を原材料に適量配合して定法に従って加工することによって得られる菓子、パン、ヨーグルト、ゼリー、冷菓、キャンデイ、ガム等である。本発明の飲料組成物は、好ましくは、ジュース類;果汁配合飲料;野菜汁配合飲料;乳飲料;茶飲料等の容器詰飲料組成物である。 The beverage composition is not particularly limited as an example of the blending form. For example, tea beverages such as green tea, oolong tea and black tea; juices such as apple juice, grapefruit juice and orange juice; fruit juice blended beverages; vegetable juice blended beverages Coffee drinks; cocoa drinks; milk drinks such as milk; carbonated drinks such as cola and cider; sports drinks; soy milk; mineral water; near water drinks; diet support drinks; Moreover, alcoholic beverages, such as beer, a sparkling wine, wine, and sake, may be sufficient. The food composition is a confectionery, bread, yogurt, jelly, frozen confectionery, candy, gum or the like obtained by blending an appropriate amount of the above composition for blending into raw materials and processing it according to a conventional method. The beverage composition of the present invention is preferably a container-packed beverage composition such as juices; fruit juice-containing beverages; vegetable juice-containing beverages; milk beverages; tea beverages.
上記飲料組成物又は食品組成物は、必要に応じて本発明の効果を損なわない範囲で、食品添加物として使用可能な各種の甘味料、酸味料、無機酸塩、無機酸塩類、有機酸、栄養強化剤、酸化防止剤、香料、色素類、乳化剤、保存料、調味料、脂質類、タンパク質類、ペプチド類、多糖類、食物繊維類、果汁エキス類、野菜エキス類、花蜜エキス類、pH調整剤等を単独或いは併用して配合してもよい。 The above beverage composition or food composition is various sweeteners, acidulants, inorganic acid salts, inorganic acid salts, organic acids that can be used as food additives, as long as the effects of the present invention are not impaired as required. Nutrition enhancer, antioxidant, flavor, pigment, emulsifier, preservative, seasoning, lipids, proteins, peptides, polysaccharides, dietary fiber, fruit juice extract, vegetable extract, nectar extract, pH You may mix | blend a regulator etc. individually or in combination.
本発明の皮膚外用剤又は化粧料の例としては、特に限定されず、例えば、乳液、クリーム、化粧水、美容液、パック、洗浄料等のスキンケア化粧料、ファンデーション、アイシャドウ、マスカラ、頬紅、口紅等のメーキャップ化粧料、養毛料、ヘアトニック、シャンプー、リンス等の頭髪用化粧料、分散液、軟膏、外用液剤、エアゾール、貼付剤、パップ剤、リニメント剤等のいずれの形態であってもよい。 Examples of the external preparation for skin or cosmetics of the present invention are not particularly limited, for example, skin care cosmetics such as milky lotion, cream, lotion, cosmetic liquid, pack, cleaning agent, foundation, eye shadow, mascara, blusher, Makeup cosmetics such as lipsticks, hair nourishing agents, hair tonics, shampoos, rinses and other hair cosmetics, dispersions, ointments, liquids for external use, aerosols, patches, poultices, liniments, etc. Good.
本発明の皮膚外用剤又は化粧料には、必要に応じて本発明の効果を損なわない範囲で、通常、化粧料や医薬部外品、外用医薬品等の製剤に使用される成分、例えば、水(例えば、アルカリ単純温泉水、深層水、精製水等を含む)、油剤、界面活性剤、金属セッケン、ゲル化剤、粉体、アルコール類、水溶性高分子、樹脂、紫外線防御剤、抗菌剤、香料、塩類、清涼剤、動物・微生物由来抽出物、植物抽出物、血行促進剤、収斂剤、抗酸化剤、美白剤、抗炎症剤、活性酸素消去剤、細胞賦活剤、保湿剤、キレート剤、角質溶解剤、酵素、ホルモン類、ビタミン類等を加えることができる。 In the external preparation for skin or cosmetics of the present invention, components that are usually used in preparations such as cosmetics, quasi-drugs, external pharmaceuticals, etc., as long as they do not impair the effects of the present invention, if necessary, such as water (For example, alkaline simple hot spring water, deep layer water, purified water, etc.), oil agent, surfactant, metal soap, gelling agent, powder, alcohol, water-soluble polymer, resin, UV protection agent, antibacterial agent , Fragrance, salt, refreshing agent, animal / microbe-derived extract, plant extract, blood circulation promoter, astringent, antioxidant, whitening agent, anti-inflammatory agent, active oxygen scavenger, cell activator, moisturizer, chelate Agents, keratolytic agents, enzymes, hormones, vitamins and the like can be added.
油剤としては、通常の皮膚外用剤又は化粧料に使用されるものであれば、天然系油であるか、合成油であるか、或いは、固体、半固体、液体であるか等の性状は問わず、炭化水素類、ロウ類、脂肪酸類、高級アルコール類、エステル油、シリコーン油類、フッ素系油類等いずれの油剤も使用することができる。例えば、スクワラン、スクワレン、セレシン、パラフィン、パラフィンワックス、流動パラフィン、プリスタン、ポリイソブチレン、マイクロクリスタリンワックス、ワセリン等の炭化水素類;ミツロウ、カルナウバロウ、キャンデリラロウ、鯨ロウ等のロウ類、牛脂、牛脚脂、牛骨脂、硬化牛脂、硬化油、タートル油、豚脂、馬脂、ミンク油、肝油、卵黄油等の動物油;ラノリン、液状ラノリン、還元ラノリン、ラノリンアルコール、硬質ラノリン、酢酸ラノリン、ラノリン脂肪酸イソプロピル、POEラノリンアルコールエーテル、POEラノリンアルコールアセテート、ラノリン脂肪酸ポリエチレングリコール、POE水素添加ラノリンアルコールエーテル等のラノリン誘導体;ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、ウンデシレン酸、オレイン酸、アラキドン酸、ドコサヘキサエン酸(DHA)、イソステアリン酸、12−ヒドロキシステアリン酸等の脂肪酸類;ラウリルアルコール、ミリスチルアルコール、パルミチルアルコール、ステアリルアルコール、ベヘニルアルコール、ヘキサデシルアルコール、オレイルアルコール、イソステアリルアルコール、ヘキシルドデカノール、オクチルドデカノール、セトステアリルアルコール、2−デシルテトラデシノール、フィトステロール、シトステロール、ラノステロール、POEコレステロールエーテル、モノステアリルグリセリンエーテル(バチルアルコール)等の高級アルコールが挙げられる。 The oil agent may be a natural oil, a synthetic oil, or a solid, semi-solid, liquid, etc., as long as it is used in normal skin external preparations or cosmetics. In addition, any oil agent such as hydrocarbons, waxes, fatty acids, higher alcohols, ester oils, silicone oils, fluorine oils and the like can be used. For example, hydrocarbons such as squalane, squalene, ceresin, paraffin, paraffin wax, liquid paraffin, pristane, polyisobutylene, microcrystalline wax, petroleum jelly; waxes such as beeswax, carnauba wax, candelilla wax, whale wax, beef tallow, cattle Animal oils such as leg fat, beef bone fat, hard beef fat, hard oil, turtle oil, pork fat, horse fat, mink oil, liver oil, egg yolk oil; lanolin, liquid lanolin, reduced lanolin, lanolin alcohol, hard lanolin, lanolin acetate, Lanolin derivatives such as lanolin fatty acid isopropyl, POE lanolin alcohol ether, POE lanolin alcohol acetate, lanolin fatty acid polyethylene glycol, POE hydrogenated lanolin alcohol ether; lauric acid, myristic acid, palmitic acid, stearin Fatty acids such as behenic acid, undecylenic acid, oleic acid, arachidonic acid, docosahexaenoic acid (DHA), isostearic acid, 12-hydroxystearic acid; lauryl alcohol, myristyl alcohol, palmityl alcohol, stearyl alcohol, behenyl alcohol, hexadecyl alcohol Higher alcohols such as oleyl alcohol, isostearyl alcohol, hexyldodecanol, octyldodecanol, cetostearyl alcohol, 2-decyltetradecinol, phytosterol, sitosterol, lanosterol, POE cholesterol ether, monostearyl glycerol ether (batyl alcohol) Can be mentioned.
界面活性剤は、油剤等の乳化や可溶化等のために用いられ、アニオン性、カチオン性、両性及び非イオン性の活性剤を用いることができる。例えば、アニオン界面活性剤としては、ステアリン酸、ラウリン酸のような脂肪酸及びそれらの無機及び有機塩、アルキルベンゼン硫酸塩、アルキルスルホン酸塩、α−オレフィンスルホン酸塩、ジアルキルスルホコハク酸塩、α−スルホン化脂肪酸塩、アシルメチルタウリン塩、N−メチル−N−アルキルタウリン塩、ポリオキシエチレンアルキルエーテル硫酸塩、ポリオキシエチレンアルキルフェニルエーテル硫酸塩、アルキル燐酸塩、ポリオキシエチレンアルキルエーテル燐酸塩、ポリオキシエチレンアルキルフェニルエーテル燐酸塩、N−アシルアミノ酸塩、N−アシル−N−アルキルアミノ酸塩、ο−アルキル置換リンゴ酸塩、アルキルスルホコハク酸塩等が挙げられる。カチオン界面活性剤としては、例えば、アルキルアミン塩、ポリアミン及びアルカノールアミン脂肪酸誘導体、アルキル四級アンモニウム塩、環式四級アンモニウム塩等が挙げられる。両性界面活性剤としては、アミノ酸タイプやベタインタイプのカルボン酸型、硫酸エステル型、スルホン酸型、リン酸エステル型のものがあり、人体に対して安全とされるものが使用できる。例えば、N,N−ジメチル−N−アルキル−N−カルボキシルメチルアンモニウムベタイン、N,N−ジアルキルアミノアルキレンカルボン酸、N,N,N−トリアルキル−N−スルフォアルキレンアンモニウムベタイン、N,N−ジアルキル−N,N−ビス(ポリオキシエチレン硫酸)アンモニウムベタイン、2−アルキル−1−ヒドロキシエチル−1−カルボキシメチルイミダゾリニウムベタイン等が挙げられる。非イオン界面活性剤としては、グリセリン脂肪酸エステル及びそのアルキレングリコール付加物、ポリグリセリン脂肪酸エステル及びそのアルキレングリコール付加物、プロピレングリコール脂肪酸エステル及びそのアルキレングリコール付加物、ソルビタン脂肪酸エステル及びそのアルキレングリコール付加物、ソルビトールの脂肪酸エステル及びそのアルキレングリコール付加物、ポリアルキレングリコール脂肪酸エステル、ショ糖脂肪酸エステル、グリセリンアルキルエーテル、ポリオキシアルキレンアルキルエーテル、ポリオキシエチレンアルキルフェニルエーテル、ポリオキシエチレン硬化ヒマシ油、ラノリンのアルキレングリコール付加物等が挙げられる。 Surfactants are used for emulsification and solubilization of oils and the like, and anionic, cationic, amphoteric and nonionic active agents can be used. For example, anionic surfactants include fatty acids such as stearic acid and lauric acid and their inorganic and organic salts, alkylbenzene sulfates, alkyl sulfonates, α-olefin sulfonates, dialkyl sulfosuccinates, α-sulfones. Fatty acid salt, acylmethyl taurine salt, N-methyl-N-alkyl taurine salt, polyoxyethylene alkyl ether sulfate, polyoxyethylene alkyl phenyl ether sulfate, alkyl phosphate, polyoxyethylene alkyl ether phosphate, polyoxy Examples thereof include ethylene alkylphenyl ether phosphate, N-acyl amino acid salt, N-acyl-N-alkyl amino acid salt, o-alkyl substituted malate, alkyl sulfosuccinate and the like. Examples of the cationic surfactant include alkylamine salts, polyamines and alkanolamine fatty acid derivatives, alkyl quaternary ammonium salts, and cyclic quaternary ammonium salts. Examples of amphoteric surfactants include amino acid type and betaine type carboxylic acid types, sulfate ester types, sulfonic acid types, and phosphate ester types, and those that are safe for the human body can be used. For example, N, N-dimethyl-N-alkyl-N-carboxylmethylammonium betaine, N, N-dialkylaminoalkylene carboxylic acid, N, N, N-trialkyl-N-sulfoalkylene ammonium betaine, N, N- Examples thereof include dialkyl-N, N-bis (polyoxyethylene sulfate) ammonium betaine and 2-alkyl-1-hydroxyethyl-1-carboxymethylimidazolinium betaine. Nonionic surfactants include glycerin fatty acid ester and its alkylene glycol adduct, polyglycerin fatty acid ester and its alkylene glycol adduct, propylene glycol fatty acid ester and its alkylene glycol adduct, sorbitan fatty acid ester and its alkylene glycol adduct, Fatty acid ester of sorbitol and its alkylene glycol adduct, polyalkylene glycol fatty acid ester, sucrose fatty acid ester, glycerin alkyl ether, polyoxyalkylene alkyl ether, polyoxyethylene alkylphenyl ether, polyoxyethylene hydrogenated castor oil, alkylene glycol of lanolin Examples include adducts.
金属セッケンとしては、脂肪酸等のアルカリ塩以外の金属塩であり、ステアリン酸アルミニウム、ステアリン酸マグネシウム、ラウリン酸亜鉛等が挙げられる。 The metal soap is a metal salt other than an alkali salt such as a fatty acid, and examples thereof include aluminum stearate, magnesium stearate, and zinc laurate.
ゲル化剤は、系の安定化や使用性、使用感を良くするために用いられ、N−ラウロイル−L−グルタミン酸等のアミノ酸誘導体、デキストリンパルミチン酸エステル等のデキストリン脂肪酸エステル、ショ糖脂肪酸エステル、有機変性粘土鉱物等が挙げられる。 Gelling agents are used to improve the stability and usability of the system, and the feeling of use. Amino acid derivatives such as N-lauroyl-L-glutamic acid, dextrin fatty acid esters such as dextrin palmitate, sucrose fatty acid esters, Examples include organically modified clay minerals.
粉体は、主としてメーキャップ化粧料における着色や皮膚の隠蔽、又は使用感を良くするため等多目的に用いられ、通常の化粧料に使用されるものであれば、その形状(球状、針状、板状、等)や粒子径(煙霧状、微粒子、顔料級等)、粒子構造(多孔質、無孔質等)を問わず、いずれのものも使用することができる。例えば、無機粉体としては、硫酸バリウム、炭酸カルシウム、タルク、雲母、合成雲母、マイカ、カオリン、セリサイト、ケイ酸、無水ケイ酸、ケイ酸アルミニウムマグネシウム、セラミックスパウダー、窒化ホウ素等が挙げられ、有機粉体としては、ポリエステルパウダー、ポリエチレンパウダー、ポリスチレンパウダー、ナイロンパウダー、ラウロイルリジン等が挙げられ、有色顔料としては、酸化鉄、カーボンブラック、酸化クロム、紺青、群青等の無機系顔料、タール系色素をレーキ化したもの、天然色素をレーキ化したものが挙げられ、パール顔料としては、酸化チタン被覆雲母、酸化チタン被覆マイカ、オキシ塩化ビスマス、酸化チタン被覆オキシ塩化ビスマス、酸化チタン被覆タルク、魚鱗箔、酸化チタン被覆着色雲母等、その他タール色素、カルミン酸等の天然色素等が挙げられる。これらの粉体を複合化したり、油剤やシリコーン、又はフッ素化合物で表面処理を行なっても良い。 The powder is mainly used for various purposes such as coloring in makeup cosmetics, hiding skin, or improving the feeling of use, and if it is used in normal cosmetics, its shape (spherical, needle-like, plate , Etc.), particle diameter (smoke, fine particles, pigment grade, etc.) and particle structure (porous, non-porous, etc.) can be used. For example, as the inorganic powder, barium sulfate, calcium carbonate, talc, mica, synthetic mica, mica, kaolin, sericite, silicic acid, anhydrous silicic acid, magnesium aluminum silicate, ceramic powder, boron nitride and the like can be mentioned, Examples of organic powders include polyester powder, polyethylene powder, polystyrene powder, nylon powder, lauroyl lysine, and colored pigments include inorganic pigments such as iron oxide, carbon black, chromium oxide, bitumen, and ultramarine blue, and tar-based pigments. Examples include pearl pigments and natural pigment lakes. Pearl pigments include titanium oxide-coated mica, titanium oxide-coated mica, bismuth oxychloride, titanium oxide-coated bismuth oxychloride, titanium oxide-coated talc, fish scales. Foil, titanium oxide-coated colored mica, etc. Other tar pigments, natural pigments such as carminic acid. These powders may be combined, or surface treatment may be performed with an oil agent, silicone, or fluorine compound.
アルコール類としてはエタノール、イソプロパノール等の低級アルコール、グリセリン、ジグリセリン、エチレングリコール、ジエチレングリコール、トリエチレングリコール、プロピレングリコール、ジプロピレングリコ−ル、1,3−ブチレングリコール、ポリエチレングリコール等が挙げられる。 Examples of alcohols include lower alcohols such as ethanol and isopropanol, glycerin, diglycerin, ethylene glycol, diethylene glycol, triethylene glycol, propylene glycol, dipropylene glycol, 1,3-butylene glycol, and polyethylene glycol.
水溶性高分子としては、アラビアゴム、トラガカント、ガラクタン、キャロブガム、グアーガム、カラヤガム、カラギーナン、ペクチン、寒天、アルゲコロイド、トラントガム、ローカストビーンガム、ガラクトマンナン等の植物系高分子、キサンタンガム、デキストラン、サクシノグルカン、プルラン等の微生物系高分子;カゼイン、アルブミン、ゼラチン等の動物系高分子;デンプン、カルボキシメチルデンプン、メチルヒドロキシプロピルデンプン等のデンプン系高分子;メチルセルロース、エチルセルロース、メチルヒドロキシプロピルセルロース、カルボキシメチルセルロース、ヒドロキシメチルセルロース、ヒドロキシプロピルセルロース、セルロース硫酸ナトリウム、カルボキシメチルセルロースナトリウム、結晶セルロース、セルロース末のセルロース系高分子;アルギン酸ナトリウム、アルギン酸プロピレングリコールエステル等のアルギン酸系高分子;ポリビニルメチルエーテル、ポリオキシエチレン系高分子;ポリオキシエチレンポリオキシプロピレン共重合体系高分子;ポリアクリル酸ナトリウム、ポリアクリルアミド等のアクリル系高分子;ポリエチレンイミン、カチオンポリマー、ベントナイト、ラポナイト、ヘクトライト等の無機系水溶性高分子や樹脂、包接化合物等が挙げられる。また、この中には、ポリビニルアルコールやポリビニルピロリドン等の皮膜形成剤も含まれる。 Examples of water-soluble polymers include gum-based polymers such as gum arabic, tragacanth, galactan, carob gum, guar gum, caraya gum, carrageenan, pectin, agar, algae colloid, trant gum, locust bean gum, galactomannan, xanthan gum, dextran, succino. Microbial polymers such as glucan and pullulan; animal polymers such as casein, albumin and gelatin; starch polymers such as starch, carboxymethyl starch and methylhydroxypropyl starch; methylcellulose, ethylcellulose, methylhydroxypropylcellulose and carboxymethylcellulose , Hydroxymethyl cellulose, hydroxypropyl cellulose, cellulose sodium sulfate, sodium carboxymethyl cellulose, crystalline cellulose Cellulose-based cellulose polymers; Alginic acid-based polymers such as sodium alginate and propylene glycol alginate; Polyvinyl methyl ether, polyoxyethylene-based polymers; Polyoxyethylene polyoxypropylene copolymer-based polymers; Sodium polyacrylate, Examples include acrylic polymers such as polyacrylamide; inorganic water-soluble polymers such as polyethyleneimine, cationic polymers, bentonite, laponite, hectorite, resins, and inclusion compounds. Also included are film forming agents such as polyvinyl alcohol and polyvinyl pyrrolidone.
樹脂としては、ポリビニルピロリドン、ビニルピロリドン・酢酸ビニル共重合体等が挙げられ、タンパク質、ムコ多糖、コラーゲン、エラスチン、ケラチン等の他の保湿剤を配合する事もできる。 Examples of the resin include polyvinyl pyrrolidone, vinyl pyrrolidone / vinyl acetate copolymer, and other humectants such as protein, mucopolysaccharide, collagen, elastin, and keratin.
塩類としては、L−アスコルビン酸リン酸エステルナトリウム塩、L−アスコルビン酸リン酸エステルマグネシウム塩、L−アスコルビン酸リン酸エステルカルシウム塩、L−アスコルビン酸リン酸エステルカリウム塩、L−アスコルビン酸硫酸エステルナトリウム塩、L−アスコルビン酸硫酸エステルマグネシウム塩、L−アスコルビン酸硫酸エステルカリウム塩、L−アスコルビン酸硫酸エステルカルシウム塩、ピロリドンカルボン酸ナトリウム、エデト酸ナトリウム、塩化ナトリウム、塩化カリウム、塩化カルシウム、塩化マグネシウム、クエン酸ナトリウム、コハク酸ナトリウム、炭酸ナトリウム、乳酸ナトリウム、乳酸カルシウム、硫酸ナトリウム、硫酸カリウム、硫酸マグネシウム、リン酸ナトリウム、リンゴ酸ナトリウム、グリチルリチン酸ジカリウム、パラフェノールスルホン酸亜鉛等が挙げられ、これらの少なくとも1種を適宜選択して用いることができる。これらの中でも、L−アスコルビン酸無機酸エステルの塩、具体的にはL−アスコルビン酸リン酸エステルナトリウム塩、L−アスコルビン酸リン酸エステルマグネシウム塩、L−アスコルビン酸リン酸エステルカルシウム塩、L−アスコルビン酸リン酸エステルカリウム塩、L−アスコルビン酸硫酸エステルナトリウム塩、L−アスコルビン酸硫酸エステルマグネシウム塩、L−アスコルビン酸硫酸エステルカリウム塩およびL−アスコルビン酸硫酸エステルカルシウム塩から選ばれる少なくとも1種が好ましい。 As salts, L-ascorbic acid phosphate sodium salt, L-ascorbic acid phosphate magnesium salt, L-ascorbic acid phosphate calcium salt, L-ascorbic acid phosphate potassium salt, L-ascorbic acid sulfate Sodium salt, L-ascorbic acid sulfate magnesium salt, L-ascorbic acid sulfate potassium salt, L-ascorbic acid sulfate calcium salt, sodium pyrrolidonecarboxylate, sodium edetate, sodium chloride, potassium chloride, calcium chloride, magnesium chloride , Sodium citrate, sodium succinate, sodium carbonate, sodium lactate, calcium lactate, sodium sulfate, potassium sulfate, magnesium sulfate, sodium phosphate, sodium malate, g Chirurichin dipotassium, zinc para-phenolsulfonate and the like, can be selected at least one of these as appropriate. Among these, salts of L-ascorbic acid inorganic acid ester, specifically, L-ascorbic acid phosphate sodium salt, L-ascorbic acid phosphate magnesium salt, L-ascorbic acid phosphate calcium salt, L- Ascorbic acid phosphate potassium salt, L-ascorbic acid sulfate sodium salt, L-ascorbic acid sulfate magnesium salt, L-ascorbic acid sulfate potassium salt and L-ascorbic acid sulfate calcium salt are preferable.
清涼剤としては、L−メントール、カンフル等、抗炎症剤としては、アラントイン、グリチルレチン酸、トラネキサム酸、アズレン等が挙げられる。 Examples of the refreshing agent include L-menthol and camphor, and examples of the anti-inflammatory agent include allantoin, glycyrrhetinic acid, tranexamic acid, and azulene.
動物または微生物由来抽出物としては、血清除蛋白、脾臓、トリ等の卵成分、卵殻膜抽出物、鶏冠抽出物、貝殻抽出物、貝肉抽出物、ローヤルゼリー、シルクプロテイン及びその分解物又はそれらの誘導体、ヘモグロビン又はその分解物、ラクトフェリン又はその分解物、イカスミ等の軟体動物、魚肉等、鳥類、貝類、昆虫類、魚類、軟体動物類等の動物由来の抽出物、霊芝抽出物等の微生物由来の抽出物等が挙げられる。動物または微生物由来抽出物を配合することによって、保湿効果、細胞賦活効果、美白効果、抗炎症効果、活性酸素除去効果、血行促進効果等を付与することができる。 Examples of extracts derived from animals or microorganisms include serum deproteinization, egg components such as spleen and birds, eggshell membrane extract, chicken crown extract, shell extract, shellfish extract, royal jelly, silk protein and their degradation products or their Microorganisms such as derivatives, hemoglobin or its degradation products, lactoferrin or its degradation products, mollusks such as squid, fish meat, birds, shellfish, insects, fish, molluscs and other animal-derived extracts, ganoderma extract The extract of origin, etc. are mentioned. By blending an animal or microorganism-derived extract, a moisturizing effect, cell activation effect, whitening effect, anti-inflammatory effect, active oxygen removal effect, blood circulation promoting effect, and the like can be imparted.
植物抽出物としては、植物の抽出部位や、抽出方法等に特に制限はなく、例えば植物の全草、又は根、茎、幹、樹皮、幼芽、葉、花、果実、種子等から抽出することが出来、これらを乾燥、細切、圧搾、或いは発酵等、適宜処理を施し、種々の適当な溶媒を用いて低温もしくは室温〜加温下で抽出することができる。抽出溶媒としては、例えば水;メチルアルコール、エチルアルコール等の低級1価アルコール;グリセリン、プロピレングリコール、1,3−ブチレングリコール等の液状多価アルコール等の1種または2種以上を用いることができる。また、ヘキサン、アセトン、酢酸エチル、エーテル等の親油性溶媒を用いて抽出することもでき、その他、スクワラン等の油性成分等により抽出したものでも良い。得られた抽出液は濾過または吸着、脱色、精製して溶液状、ペースト状、ゲル状、粉末状とすることもできる。必要ならば、効果に影響のない範囲で更に、脱臭、脱色等の精製処理をしても良い。植物としては、アスパラガス、ノイバラ(エイジツ)、キイチゴ、クララ(クジン)、ケイケットウ、ゴカヒ、コーヒー、コメ、サイシン、サンザシ、シラユリ、シャクヤク、茶、ブナ、ブドウ、ホップ、モッカ、ユキノシタ、アルテア、アシタバ、アルニカ、インチンコウ、イラクサ、キハダ(オウバク)、オトギリソウ、スイカズラ(キンギンカ)、サルビア(セージ)、シコン、シラカバ、ムクロジ、レンゲソウ、イチョウ、オオムギ、センブリ、ナツメ(タイソウ)、ローズマリー(マンネンロウ)、オウレン、グレープフルーツ、ゲンチアナ、サボンソウ、ショウブ、ジオウ、センキュウ、ゼニアオイ(ウスベニタチアオイ)、ハマメリス、フキタンポポ、プルーン、ボダイジュ、マロニエ、マルメロ等が挙げられる。植物抽出物を配合することによって、保湿効果、細胞賦活効果、美白効果、抗炎症効果、活性酸素除去効果、血行促進効果等を付与することができる。(尚、かっこ内は、植物の別名、生薬名等を記載した。) The plant extract is not particularly limited in terms of plant extraction site, extraction method, and the like, and is extracted from, for example, whole plant plants, roots, stems, stems, bark, shoots, leaves, flowers, fruits, seeds, or the like. These can be appropriately treated, such as dried, shredded, pressed, or fermented, and extracted using various appropriate solvents at a low temperature or from room temperature to warming. As the extraction solvent, for example, water; a lower monohydric alcohol such as methyl alcohol or ethyl alcohol; or a liquid polyhydric alcohol such as glycerin, propylene glycol, or 1,3-butylene glycol can be used. . Moreover, it can also extract using lipophilic solvents, such as hexane, acetone, ethyl acetate, and ether, and what was extracted with oily components, such as squalane, may be used. The obtained extract may be filtered, adsorbed, decolored and purified to form a solution, paste, gel or powder. If necessary, purification treatment such as deodorization and decolorization may be further performed within a range not affecting the effect. Plants include asparagus, Neubara (Ages), raspberry, Clara (Kujin), caquette, gokahi, coffee, rice, saishin, hawthorn, white lilies, peonies, tea, beech, grapes, hops, mokka, yukinoshita, altea, ashitaba , Arnica, Ginseng, Nettle, Yellowfin, Hypericum, Honeysuckle (Ginkgo), Salvia (Sage), Siphon, Birch, Mulberry, Forsythia, Ginkgo, Barley, Assembly, Jujube, Rosemary , Grapefruit, gentian, savonso, shobu, jiou, senkyu, mallow (Husbenitachaoi), hamamelis, dandelion, prune, bodaiju, maronier, quince and the like. By blending a plant extract, a moisturizing effect, a cell activation effect, a whitening effect, an anti-inflammatory effect, an active oxygen removal effect, a blood circulation promoting effect and the like can be imparted. (In parentheses, plant aliases and herbal medicine names are listed.)
活性酸素除去剤は、紫外線による過酸化脂質の生成などを抑制する目的で用いられ、スーパーオキサイドディスムターゼ、マンニトール、クエルセチン、カテキン及びその誘導体、チアミン類(チアミン塩酸塩、チアミン硫酸塩)、リボフラビン類(リボフラビン、酢酸リボフラビン等)、ピリドキシン類(塩酸ピリドキシン、ピリドキシンジオクタノエート等)、ニコチン酸類(ニコチン酸アミド、ニコチン酸ベンジル等)等のビタミンB類;ジブチルヒドロキシトルエン及びブチルヒドロキシアニソール等が挙げられる。これらの活性酸素除去剤を配合することによって、くすみを抑制し、より高い老化防止効果を発揮することができる。 The active oxygen scavenger is used for the purpose of suppressing the production of lipid peroxide by ultraviolet rays, and superoxide dismutase, mannitol, quercetin, catechin and its derivatives, thiamines (thiamine hydrochloride, thiamine sulfate), riboflavins ( Riboflavin, riboflavin acetate, etc.), pyridoxines (pyridoxine hydrochloride, pyridoxine dioctanoate, etc.), nicotinic acids (nicotinic acid amide, nicotinic acid benzyl, etc.) vitamin B; dibutylhydroxytoluene, butylhydroxyanisole, etc. . By blending these active oxygen scavengers, dullness can be suppressed and a higher anti-aging effect can be exhibited.
細胞賦活剤としては、カロチノイド(カロチン、リコピン、アスタキサンチン等)、ビタミンA及びその誘導体(パルミチン酸レチノール、酢酸レチノール等のレチノール及びその誘導体;デヒドロレチナール等のレチナール及びその誘導体等)、ビタミンC及びその誘導体(ジパルミチン酸L−アスコルビルやテトライソパルミチン酸L−アスコルビル等のL−アスコルビン酸アルキルエステル、L−アスコルビン酸リン酸エステル、L−アスコルビン酸硫酸エステル等)、ビタミンB及びその誘導体(チアミン塩酸塩、チアミン硫酸塩、リボフラビン、酢酸リボフラビン、塩酸ピリドキシン、ピリドキシンジオクタノエート、フラビンアデニンジヌクレオチド、シアノコバラミン、葉酸類、ニコチン酸アミドやニコチン酸ベンジル等のニコチン酸類、コリン類等)、リボ核酸及びその塩、デオキシリボ核酸及びその塩、α−及びγ−リノレン酸、キサンチン及びその誘導体(カフェイン等)、アミノ酸及びその誘導体(セリン、グルタミン酸、テアニン、ヒドロキシプロリン、ピロリドンカルボン酸等)、ドコサヘキサエン酸及びその誘導体、エイコサペンタエン酸及びその誘導体、クエン酸、乳酸、リンゴ酸、コハク酸、アーモンド抽出物、アンズ(キョウニン)抽出物、イチョウ抽出物、キハダ(オウバク)抽出物、オオムギ(バクガ)抽出物、キウイ抽出物、キュウリ抽出物、シイタケ抽出物、スギナ抽出物、センブリ抽出物、大豆抽出物、ナツメ(タイソウ)抽出物、ツボクサ抽出物、トウガラシ抽出物、トウキンセンカ抽出物、トマト抽出物、ニンニク抽出物、ニンジン抽出物、ブクリョウ抽出物、ブドウ種子油、ブナノキ抽出物、ブナの芽抽出物、モモ抽出物、ユーカリ抽出物、ユリ抽出物、レタス抽出物、レモン抽出物、ローズマリー(マンネンロウ)抽出物、麦芽根抽出物、動物由来抽出物(イカスミ等軟体動物抽出物、貝殻抽出物、貝肉抽出物、魚肉抽出物、鶏冠抽出物、ローヤルゼリー、シルクプロテイン及びその分解物、胎盤抽出物、血清除蛋白抽出物、ラクトフェリン又はその分解物等)、酵母抽出物、微生物醗酵代謝産物(乳酸菌、ビフィズス菌等由来)、霊芝抽出物等が挙げられる。これらの細胞賦活剤は一種又は二種以上を組み合わせて用いることができる。 Examples of cell activators include carotenoids (such as carotene, lycopene, astaxanthin), vitamin A and derivatives thereof (retinol such as retinol palmitate and retinol acetate; and retinals such as dehydroretinal and derivatives thereof), vitamin C and its derivatives. Derivatives (L-ascorbic acid alkyl esters such as L-ascorbyl dipalmitate and L-ascorbyl tetraisopalmitate, L-ascorbic acid phosphate, L-ascorbic acid sulfate, etc.), vitamin B and its derivatives (thiamine hydrochloride) Salt, thiamine sulfate, riboflavin, riboflavin acetate, pyridoxine hydrochloride, pyridoxine dioctanoate, flavin adenine dinucleotide, cyanocobalamin, folic acid, nicotinamide and benzyl nicotinate (Tinic acids, choline, etc.), ribonucleic acid and salts thereof, deoxyribonucleic acid and salts thereof, α- and γ-linolenic acid, xanthine and derivatives thereof (caffeine, etc.), amino acids and derivatives thereof (serine, glutamic acid, theanine, hydroxy) Proline, pyrrolidone carboxylic acid, etc.), docosahexaenoic acid and its derivatives, eicosapentaenoic acid and its derivatives, citric acid, lactic acid, malic acid, succinic acid, almond extract, apricot extract, ginkgo biloba extract, yellowfin ) Extract, Barley (Bakuga) extract, Kiwi extract, Cucumber extract, Shiitake extract, Japanese horse chestnut extract, Assembly extract, Soybean extract, Jujube extract, Rhizoma extract, Pepper extract, Tokachinka extract, tomato extract, garlic extract, garlic Extract, Bukuryu extract, Grape seed oil, Beech extract, Beech sprout extract, Peach extract, Eucalyptus extract, Lily extract, Lettuce extract, Lemon extract, Rosemary extract, Malt Root extract, animal-derived extract (mollusk and other mollusc extracts, shell extract, shellfish extract, fish extract, chicken crown extract, royal jelly, silk protein and its degradation products, placenta extract, serum deproteinization extraction Product, lactoferrin or its degradation product), yeast extract, microbial fermentation metabolite (derived from lactic acid bacteria, bifidobacteria, etc.), ganoderma extract and the like. These cell activators can be used alone or in combination of two or more.
保湿剤としては、コラーゲン、エラスチン、ケラチン等のタンパク質またはそれらの誘導体、加水分解物並びにそれらの塩、ヒアルロン酸、コンドロイチン硫酸等のムコ多糖及びその誘導体、セリン、グリシン、テアニン、アスパラギン酸等のアミノ酸及びそれらの誘導体、ソルビトール、エリスリトール、トレハロース、イノシトール、グルコース、キシリトール、蔗糖およびその誘導体、デキストリン及びその誘導体、ハチミツ等の糖類、D−パンテノール及びその誘導体、糖脂質、セラミド等が挙げられる。これらの保湿剤を配合することにより、より高い老化防止効果を発揮し、透明感のある肌を実現することができる。 Examples of moisturizers include proteins such as collagen, elastin and keratin or derivatives thereof, hydrolysates and salts thereof, mucopolysaccharides and derivatives thereof such as hyaluronic acid and chondroitin sulfate, amino acids such as serine, glycine, theanine and aspartic acid. And derivatives thereof, sorbitol, erythritol, trehalose, inositol, glucose, xylitol, sucrose and derivatives thereof, dextrin and derivatives thereof, saccharides such as honey, D-pantenol and derivatives thereof, glycolipid, ceramide and the like. By blending these moisturizers, it is possible to achieve a higher anti-aging effect and realize a transparent skin.
キレート剤としては、例えばエデト酸、エタンヒドロキシジホスフェート、ピロリン酸塩、ヘキサメタリン酸塩、クエン酸、酒石酸、グルコン酸並びにこれらの塩類等を使用することができる。 As the chelating agent, for example, edetic acid, ethane hydroxydiphosphate, pyrophosphate, hexametaphosphate, citric acid, tartaric acid, gluconic acid, and salts thereof can be used.
抗酸化剤としては、マンニトール、ベータカロチン、アスタキサンチン、ルチン及びその誘導体、クエルセチン、リン脂質、レチノール及びその誘導体(パルミチン酸レチノール、酢酸レチノール等)、レチナール及びその誘導体、デヒドロレチナール、カロチン等のカロチノイド等のビタミンA類、ピリドキシン類(塩酸ピリドキシン、ピリドキシンジオクタノエート等)、ニコチン酸類(ニコチン酸アミド、ニコチン酸ベンジル等)、ジブチルヒドロキシトルエン(BHT)、ブチルヒドロキシアニソール(BHA)、ビタミンE及びその誘導体並びにそれらの塩、ニンジン抽出物、メリッサ抽出物、ヤシャジツ抽出物等が挙げられる。これらの抗酸化剤のうち、特に好ましいものとしては、ビタミンE及びその誘導体並びにそれらの塩が挙げられる。 Antioxidants include mannitol, beta carotene, astaxanthin, rutin and derivatives thereof, quercetin, phospholipid, retinol and derivatives thereof (such as retinol palmitate, retinol acetate), retinal and derivatives thereof, carotenoids such as dehydroretinal and carotene Vitamins A, pyridoxines (pyridoxine hydrochloride, pyridoxine dioctanoate, etc.), nicotinic acids (nicotinic acid amide, benzyl nicotinate, etc.), dibutylhydroxytoluene (BHT), butylhydroxyanisole (BHA), vitamin E and its Derivatives and salts thereof, carrot extract, Melissa extract, Yashajitsu extract and the like. Among these antioxidants, vitamin E and derivatives thereof and salts thereof are particularly preferable.
美白剤としては、ビタミンC及びその誘導体並びにそれらの塩、アルブチン、ハイドロキノン及びその誘導体、コウジ酸、エラグ酸、トラネキサム酸及びその誘導体、胎盤抽出物、甘草抽出物、ヨクイニン抽出物、アスパラガス抽出物、エイジツ抽出物、キウイ抽出物、キイチゴ抽出物、クジン抽出物、ケイケットウ抽出物、ゴカヒ抽出物、コーヒー抽出物、コメヌカ抽出物、小麦胚芽抽出物、サイシン抽出物、サンザシ抽出物、シラユリ抽出物、シャクヤク抽出物、大豆抽出物、緑茶、紅茶、ウーロン茶等の茶抽出物、糖蜜抽出物、ビャクレン抽出物、ブナの芽抽出物、ブドウ抽出物、ホップ抽出物、マイカイカ抽出物、モッカ抽出物及び羅漢果抽出物、オウゴン抽出物、海藻抽出物等が挙げられる。これらの美白剤のうち、特に好ましいものとしては、ビタミンC及びその誘導体並びにそれらの塩が挙げられる。 Examples of whitening agents include vitamin C and derivatives thereof and salts thereof, arbutin, hydroquinone and derivatives thereof, kojic acid, ellagic acid, tranexamic acid and derivatives thereof, placenta extract, licorice extract, yokuinin extract, asparagus extract , Agetsu extract, Kiwi extract, Raspberry extract, Kujin extract, Keiket extract, Gokahi extract, Coffee extract, Rice bran extract, Wheat germ extract, Saisin extract, Hawthorn extract, Shirayuri extract, Peonies extract, soybean extract, tea extract such as green tea, black tea, oolong tea, molasses extract, beechlen extract, beech bud extract, grape extract, hop extract, micaika extract, mokka extract and rakan fruit Examples include extracts, ougon extracts, seaweed extracts, and the like. Among these whitening agents, vitamin C and its derivatives and salts thereof are particularly preferable.
血行促進剤は、皮膚の血流をうながすことによってメラニンの排出を促進する目的で用いられ、トウガラシチンキ、γ―オリザノール等が挙げられ、酵素としてはリパーゼ、パパイン等が挙げられる。 The blood circulation promoter is used for the purpose of promoting melanin excretion by promoting the blood flow of the skin, such as chili pepper tincture and γ-oryzanol. Enzymes include lipase and papain.
皮膚収斂剤としてはタンニン酸等、抗脂漏剤としてはチアントロール等、酵素としてはリパーゼ、パパイン等が挙げられる。 Examples of skin astringents include tannic acid, examples of antiseborrheic agents include thianthol, and examples of enzymes include lipase and papain.
抗炎症剤としては、グリチルリチン酸及びその誘導体、グリチルレチン酸及びその誘導体等が挙げられる。 Anti-inflammatory agents include glycyrrhizic acid and its derivatives, glycyrrhetinic acid and its derivatives, and the like.
紫外線防止剤としては、パラメトキシケイ皮酸−2−エチルヘキシル、オキシベンゾン、4−tert−ブチル−4’−メトキシジベンゾイルメタン、2−ヒドロキシ−4−メトキシベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン−5−スルホン酸、2−ヒドロキシ−4−メトキシベンゾフェノン−5−スルホン酸ナトリウム、2−ヒドロキシ−4−メトキシベンゾフェノン−5−硫酸ナトリウム、2−フェニルベンズイミダゾール硫酸ナトリウム、酸化チタン、酸化亜鉛等が挙げられる。 Examples of UV inhibitors include paramethoxycinnamate-2-ethylhexyl, oxybenzone, 4-tert-butyl-4′-methoxydibenzoylmethane, 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxybenzophenone- 5-sulfonic acid, 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid sodium, 2-hydroxy-4-methoxybenzophenone-5-sodium sulfate, 2-phenylbenzimidazole sodium sulfate, titanium oxide, zinc oxide, etc. It is done.
抗菌剤は、ニキビなどを予防、改善する目的で用いられ、安息香酸、安息香酸ナトリウム、パラオキシ安息香酸エステル、パラクロルメタクレゾール、塩化ベンザルコニウム、フェノキシエタノール、イソプロピルメチルフェノール等が挙げられる。 Antibacterial agents are used for the purpose of preventing and improving acne and the like, and include benzoic acid, sodium benzoate, paraoxybenzoic acid ester, parachlormetacresol, benzalkonium chloride, phenoxyethanol, isopropylmethylphenol and the like.
酵素としてはリパーゼ、パパイン等が挙げられる。 Examples of the enzyme include lipase and papain.
ホルモン類としてはメラトニンおよびその誘導体、副腎皮質ホルモンおよびその誘導体、植物ホルモン(オーキシン、サイトカイニン、ジベレリン、カイネチン、アブシジン酸、エチレン等)およびその誘導体等があげられる。 Examples of hormones include melatonin and derivatives thereof, adrenocortical hormones and derivatives thereof, plant hormones (auxin, cytokinin, gibberellin, kinetin, abscisic acid, ethylene, etc.) and derivatives thereof.
ビタミン類としては、例えばビタミンA、ビタミンB、ビタミンC、ビタミンD、ビタミンF、ビタミンK、ビタミンP、ビタミンU、カルニチン及びその誘導体、ビタミンE及びその誘導体等が挙げられる。 Examples of vitamins include vitamin A, vitamin B, vitamin C, vitamin D, vitamin F, vitamin K, vitamin P, vitamin U, carnitine and derivatives thereof, vitamin E and derivatives thereof, and the like.
次に実施例を挙げて本発明を更に詳細に説明するが、本発明はこれらに限定されるものではない。 EXAMPLES Next, although an Example is given and this invention is demonstrated further in detail, this invention is not limited to these.
試験例1.葉酸の光安定性試験
(実施例1〜4、比較例1〜16)
表1、表2に示す組成の水溶液を下記の方法により調製した。葉酸の外観安定性、匂い安定性について以下に示す方法及び基準により評価判定し、結果を併せて表1、表2に示した。
Test Example 1 Photostability test of folic acid (Examples 1-4, Comparative Examples 1-16)
Aqueous solutions having the compositions shown in Tables 1 and 2 were prepared by the following method. The appearance stability and odor stability of folic acid were evaluated and determined by the following methods and criteria, and the results are shown in Tables 1 and 2 together.
(調整方法)
A:成分24に成分1および成分2〜20のいずれか1種の成分を混合溶解させる(この時点ではAは溶解せず分散するのみである)。
B:Aに成分21、22を混合溶解させる。
C:Bに成分23を添加し、25℃でのpHが6.0以上になるよう調整し、成分1を溶解させることで葉酸の水溶液を得た。
(Adjustment method)
A: Component 1 and any one of components 2 to 20 are mixed and dissolved in component 24 (A is not dissolved but only dispersed at this point).
B: Components 21 and 22 are mixed and dissolved in A.
C: Component 23 was added to B, the pH at 25 ° C. was adjusted to 6.0 or more, and component 1 was dissolved to obtain an aqueous solution of folic acid.
(評価方法)
調製した各水溶液50gを8号ガラス規格瓶に充填し、蛍光灯により8000ルクスの光が照射された30℃のチャンバー内に静置した。試験開始1日後、3日後、14日後にガラス規格瓶をチャンバーから取り出し、アルミホイルで遮光してチャンバー内に保存した各水溶液を基準として、経時での外観変化(水溶液の透明性や沈殿の析出の有無)を観察した。また、試験開始1日後において×と評価されたサンプルは評価終了とし、その後の評価は行わなかった。匂い変化は、試験開始14日後にガラス規格瓶をチャンバーから取り出し、蓋を開けて、専門パネル員10名が調製直後の各水溶液を基準とし、匂いの官能評価を行なった。
(Evaluation method)
50 g of each prepared aqueous solution was filled in a No. 8 glass standard bottle, and allowed to stand in a chamber at 30 ° C. irradiated with light of 8000 lux by a fluorescent lamp. After 1 day, 3 days, and 14 days after the start of the test, the glass standard bottle was taken out from the chamber, shielded with aluminum foil and stored in the chamber, and the appearance change over time (transparency of the aqueous solution and precipitation of precipitation) The presence or absence of was observed. Moreover, the sample evaluated as x one day after the start of the test was evaluated, and the subsequent evaluation was not performed. Regarding the odor change, the glass standard bottle was taken out from the chamber 14 days after the start of the test, the lid was opened, and 10 expert panel members performed sensory evaluation of the odor based on each aqueous solution immediately after preparation.
(評価方法:外観安定性(濁度、変色、沈殿のなさ))
専門パネル員が下記基準により評価を行った。
透明性が変化せず、変色や沈殿も確認されない:◎
わずかに濁度が上昇するが、変色や沈殿は確認されない:○
わずかに変色および沈殿が確認される:△
変色・沈殿が明らかに確認される:×
(Evaluation method: Appearance stability (turbidity, discoloration, no precipitation))
Specialist panel members evaluated the following criteria.
Transparency does not change, and no discoloration or precipitation is confirmed: ◎
Slightly increases in turbidity, but no discoloration or precipitation is confirmed: ○
Slight discoloration and precipitation are confirmed: △
Discoloration and precipitation are clearly confirmed: ×
(評価方法:匂い安定性(変臭のなさ))
各専門パネル員が、各サンプルについて下記基準により評価を行い、更に10人の平均点から以下のように判定した。
(評価基準:変臭)
全く変化がない:4点
ほとんど変化がない:3点
やや変化がある:2点
明らかに変化がある:1点
(判定基準:変臭)
◎:3.5点以上
○:3.0点以上3.5点未満
△:2.0点以上3.0点未満
×:1.5点未満
(Evaluation method: odor stability (no odor change))
Each expert panel member evaluated each sample according to the following criteria, and further determined from the average score of 10 people as follows.
(Evaluation criteria: Odor)
No change: 4 points Almost no change: 3 points Some change: 2 points Clearly change: 1 point (Criteria: Odor)
◎: 3.5 points or more ○: 3.0 points or more and less than 3.5 points Δ: 2.0 points or more and less than 3.0 points ×: less than 1.5 points
表1、表2から明らかなように、本実施例1〜4の水溶液は14日後まで外観と匂いに変化はほとんど生じず、葉酸の光安定化効果に優れていた。一方、比較例2〜4については、葉酸は3日後まではあまり変化しなかったが、14日後までは安定性を保つことができず、激しい変臭もしくは沈殿・変色が確認された。比較例1、及び5〜16については葉酸の光安定性が1日すら保たれない結果となった。抗酸化剤として知られるピロ亜硫酸塩(比較例15)、紫外線吸収剤として知られるヒドロキシメトキシベンゾフェノンスルホン酸ナトリウム(比較例16)にも葉酸の光安定化効果はなかった。 As can be seen from Tables 1 and 2, the aqueous solutions of Examples 1 to 4 had almost no change in appearance and odor until after 14 days, and were excellent in the photostabilization effect of folic acid. On the other hand, in Comparative Examples 2 to 4, although folic acid did not change much until 3 days later, stability could not be maintained until 14 days later, and severe odor or precipitation / discoloration was confirmed. For Comparative Examples 1 and 5 to 16, the photostability of folic acid was not maintained even for one day. Pyrosulfite (Comparative Example 15), known as an antioxidant, and sodium hydroxymethoxybenzophenone sulfonate (Comparative Example 16), known as an ultraviolet absorber, did not have a photostabilizing effect of folic acid.
試験例2.葉酸の光安定性試験及び使用性試験
(実施例5〜11)
葉酸とアミノ酸(代表してリジン)の配合比率について検討するために、表3に示す組成の水溶液を下記調整方法により調製した。葉酸の外観安定性、匂い安定性、使用性について以下に示す方法及び基準により評価判定し、結果を併せて表3に示した。
Test Example 2 Photostability test and usability test of folic acid (Examples 5 to 11)
In order to examine the blending ratio of folic acid and amino acid (typically lysine), an aqueous solution having the composition shown in Table 3 was prepared by the following adjustment method. The appearance stability, odor stability, and usability of folic acid were evaluated and determined by the following methods and criteria, and the results are shown in Table 3.
(調整方法)
A:成分6に成分1、2を混合溶解させる(この時点では成分1は溶解せず分散するのみ)。
B:Aに成分3、4を混合溶解させる。
C:Bに成分5を添加し、25℃でのpHが6以上になるよう調整し、成分1を溶解させることで水溶液を得た。
(Adjustment method)
A: Components 1 and 2 are mixed and dissolved in component 6 (component 1 is not dissolved but only dispersed at this point).
B: Components 3 and 4 are mixed and dissolved in A.
C: Component 5 was added to B, the pH at 25 ° C. was adjusted to 6 or more, and component 1 was dissolved to obtain an aqueous solution.
(評価方法:外観安定性、匂い安定性)
前述の試験例1と同様に外観安定性(濁度、変色、沈殿のなさ)、匂い安定性(変臭のなさ)について、評価・判定を行った。
(Evaluation method: appearance stability, odor stability)
In the same manner as in Test Example 1 described above, appearance stability (turbidity, discoloration, no precipitation) and odor stability (no odor change) were evaluated and judged.
(評価方法:使用性(べたつきのなさ))
専門パネル員10名が、調製直後の各サンプルを前腕内側部に塗布し、塗布中及び塗布後のべたつきについて下記基準により評価を行い、更に10人の平均点から以下のように判定した。
(評価基準)
ほとんどべたつきを感じない:4点
ややべたつきを感じる:3点
明らかにべたつきを感じる:2点
不快なべたつきを感じる:1点
(判定基準)
◎:3.5点以上
○:3.0点以上3.5点未満
△:2.0点以上3.0点未満
×:1.5点未満
(Evaluation method: Usability (no stickiness))
Ten professional panel members applied each sample immediately after preparation to the inner side of the forearm, evaluated the stickiness during and after application according to the following criteria, and further determined from the average score of 10 people as follows.
(Evaluation criteria)
Feels almost non-sticky: 4 points, feels slightly sticky: 3 points clearly feels sticky: 2 points Feels unpleasant stickiness: 1 point (criteria)
◎: 3.5 points or more ○: 3.0 points or more and less than 3.5 points Δ: 2.0 points or more and less than 3.0 points ×: less than 1.5 points
表2に示すように、実施例5〜11の範囲において葉酸の光安定性は保たれており、べたつきについても使用に際して問題はないものであった。また、葉酸に対してアミノ酸の配合量が5倍以上になると葉酸の安定性はより向上するが、べたつきを感じやすくなる傾向にあることがわかった。一方、アミノ酸の比率を下げるとべたつきは軽減されるが、葉酸の光安定性は低下する傾向にあった。 As shown in Table 2, the photostability of folic acid was maintained in the range of Examples 5 to 11, and stickiness was not a problem in use. Further, it was found that when the blending amount of amino acid with respect to folic acid is 5 times or more, the stability of folic acid is further improved, but stickiness tends to be felt. On the other hand, when the ratio of amino acids was lowered, stickiness was reduced, but the photostability of folic acid tended to decrease.
試験例3.葉酸の光安定性試験及び使用性試験
(実施例12〜14、比較例17)
葉酸の光安定性を更に高める方法を検討するために、表4に示す組成の水溶液を下記調整方法により調製した。葉酸の外観安定性、匂い安定性、使用性について以下に示す方法及び基準により評価判定し、結果を併せて表4に示した。
Test Example 3 Photostability test and usability test of folic acid (Examples 12 to 14, Comparative Example 17)
In order to study a method for further improving the photostability of folic acid, an aqueous solution having the composition shown in Table 4 was prepared by the following adjustment method. The appearance stability, odor stability, and usability of folic acid were evaluated and determined by the following methods and criteria. The results are also shown in Table 4.
(調整方法)
A:成分8に成分1、2を混合溶解させる(この時点ではAは溶解せず分散するのみ)。
B:Aに成分5、6を混合溶解させる。
C:Bに成分7を添加し、pHが6以上になるよう調整し、成分1を溶解させる。
D:Cに成分3、4のいずれか1種を添加混合させる。
(Adjustment method)
A: Components 1 and 2 are mixed and dissolved in component 8 (A is not dissolved but only dispersed at this point).
B: Components 5 and 6 are mixed and dissolved in A.
C: Component 7 is added to B, the pH is adjusted to 6 or more, and component 1 is dissolved.
D: Any one of components 3 and 4 is added to C and mixed.
(評価方法)
前述の試験例2と同様にして外観安定性(濁度、変色、沈殿のなさ)、匂い安定性(変臭のなさ)、使用性(べたつきのなさ)について、評価・判定を行った。なお、試験開始1日後、3日後の評価は省略した。
(Evaluation method)
In the same manner as in Test Example 2 described above, appearance stability (turbidity, discoloration, no precipitation), odor stability (no discoloration), and usability (no stickiness) were evaluated and judged. Note that the evaluation after 1 day and 3 days after the start of the test was omitted.
表3に水溶性高分子の添加による効果を示した。実施例12に示されるように、カルボキシル基をもつ水溶性高分子であるアルキル変性カルボキシビニルポリマーを併用することで、葉酸の光安定性がさらに向上した。比較例17に示されるように、リジンを配合せず、アルキル変性カルボキシビニルポリマーと葉酸を併用しただけでは、葉酸は光に対して安定にはならなかった。 Table 3 shows the effect of adding a water-soluble polymer. As shown in Example 12, the light stability of folic acid was further improved by using an alkyl-modified carboxyvinyl polymer that is a water-soluble polymer having a carboxyl group. As shown in Comparative Example 17, folic acid was not stable to light when lysine was not added and only the alkyl-modified carboxyvinyl polymer and folic acid were used in combination.
実施例15:化粧水(水中油型乳化組成物)
(成分) (質量%)
1.水素添加大豆リン脂質*1 1.0
2.1,3―ブチレングリコール 3.0
3.1,2−ペンタンジオール 1.0
4.グリセリン 5.0
5.2―エチルヘキサン酸セチル 1.0
6.ラウロイルグルタミン酸
ジ(フィトステリル/オクチルドデシル) 0.5
7.精製水 20.0
8.葉酸 0.1
9.アルギニン 0.2
10.リン酸一水素ナトリウム 0.05
11.リン酸二水素ナトリウム 0.05
12.水酸化ナトリウム 0.0144
13.アルコール 5.0
14.精製水 残量
*1:ベイシスLS−60HR(日清オイリオグループ社製)
Example 15: Lotion (oil-in-water emulsion composition)
(Ingredient) (mass%)
1. Hydrogenated soybean phospholipid * 1 1.0
2.1,3-butylene glycol 3.0
3. 1,2-pentanediol 1.0
4). Glycerin 5.0
5.2-cetyl ethyl hexanoate 1.0
6). Lauroyl glutamic acid
Di (phytosteryl / octyldodecyl) 0.5
7). Purified water 20.0
8). Folic acid 0.1
9. Arginine 0.2
10. Sodium monohydrogen phosphate 0.05
11. Sodium dihydrogen phosphate 0.05
12 Sodium hydroxide 0.0144
13. Alcohol 5.0
14 Purified water remaining * 1: Basis LS-60HR (Nisshin Oillio Group)
(製法)
A:成分1〜4を70℃で均一に混合する。
B:成分5〜6を70℃で均一に溶解する。
C:成分7を70℃で均一に溶解する。
D:AにBを添加し均一に混合する。
E:DにCを添加し乳化する。
F:Eに8〜14を添加し、冷却し化粧水を得た。
(Manufacturing method)
A: Components 1 to 4 are uniformly mixed at 70 ° C.
B: Components 5 to 6 are uniformly dissolved at 70 ° C.
C: Component 7 is uniformly dissolved at 70 ° C.
D: Add B to A and mix uniformly.
E: C is added to D and emulsified.
F: 8 to 14 was added to E and cooled to obtain a lotion.
実施例15の化粧水は、光により劣化する油溶性薬剤である葉酸の光に対する外観安定性、変臭のなさ、べたつきの無さ及び製剤の安定性に非常に優れるものであった。 The lotion of Example 15 was very excellent in the appearance stability of folic acid, which is an oil-soluble drug that deteriorates due to light, to light, no odor change, no stickiness, and the stability of the preparation.
実施例16:化粧水(可溶化透明タイプ)
(成分) (質量%)
1.1,2−ペンタンジオール 1.0
2.精製水 30.0
3.POE(20)POP(6)
デシルテトラデシルエーテル 0.3
4.パラオキシ安息香酸メチル 0.05
5.香料 適量
6.l―メントール 0.1
7.エタノール 10.0
8.葉酸 0.01
9.ヒドロキシプロリン 0.05
10.クエン酸 0.02
11.リン酸二水素ナトリウム 0.05
12.水酸化ナトリウム 0.0134
13.精製水 残量
Example 16: lotion (solubilized transparent type)
(Ingredient) (mass%)
1.1,2-Pentanediol 1.0
2. Purified water 30.0
3. POE (20) POP (6)
Decyl tetradecyl ether 0.3
4). Methyl paraoxybenzoate 0.05
5. Perfume appropriate amount 6. l-Menthol 0.1
7). Ethanol 10.0
8). Folic acid 0.01
9. Hydroxyproline 0.05
10. Citric acid 0.02
11. Sodium dihydrogen phosphate 0.05
12 Sodium hydroxide 0.0134
13. Purified water remaining
(製法)
A:成分3〜7を混合溶解する。
B:Aに成分1、2を添加し均一に混合溶解する。
C:Bに成分8〜13を添加し、均一に混合溶解させ化粧水を得た。
(Manufacturing method)
A: Components 3 to 7 are mixed and dissolved.
B: Components 1 and 2 are added to A and mixed and dissolved uniformly.
C: Components 8 to 13 were added to B, and mixed and dissolved uniformly to obtain a skin lotion.
実施例16の化粧水は、光により劣化する葉酸の光に対する安定性、変臭のなさ、べたつきの無さ及び製剤の安定性に非常に優れるものであった。 The lotion of Example 16 was very excellent in the stability of the folic acid, which deteriorates due to light, to light, no odor change, no stickiness, and the stability of the preparation.
実施例17:乳液
(成分) (質量%)
1.ステアリルアルコール 2.0
2.ワセリン 3.0
3.トリ2−エチルヘキサン酸グリセリル 5.0
4.酸化チタン 2.0
5.雲母チタン 2.0
6.ステアリン酸ナトリウム 1.0
7.カルボキシビニルポリマー 0.1
8.1,3−ブチレングリコール 10.0
9.葉酸 0.2
10.リジン 0.05
11.乳酸 0.05
12.乳酸ナトリウム 0.05
13.水酸化ナトリウム 0.0134
14.防腐剤 適量
15.香料 適量
16.精製水 残量
Example 17: Latex (component) (mass%)
1. Stearyl alcohol 2.0
2. Vaseline 3.0
3. Glyceryl tri-2-ethylhexanoate 5.0
4). Titanium oxide 2.0
5. Mica titanium 2.0
6). Sodium stearate 1.0
7). Carboxyvinyl polymer 0.1
8.1,3-Butylene glycol 10.0
9. Folic acid 0.2
10. Lysine 0.05
11. Lactic acid 0.05
12 Sodium lactate 0.05
13. Sodium hydroxide 0.0134
14 Preservative appropriate amount15. Perfume appropriate amount 16. Purified water remaining
(製法)
A.成分1〜5を75℃に加熱し、均一に混合する。
B.成分6〜8、16を75℃に加熱し、均一に混合する。
C.BにAを添加し、乳化する。
D.Cを冷却し、成分9〜15を添加し、乳液を得た。
(Manufacturing method)
A. Ingredients 1-5 are heated to 75 ° C. and mixed uniformly.
B. Ingredients 6-8, 16 are heated to 75 ° C. and mixed uniformly.
C. Add A to B and emulsify.
D. C was cooled and ingredients 9-15 were added to obtain an emulsion.
実施例17の乳液は、光により劣化する葉酸の光に対する安定性、変臭のなさ、べたつきの無さ及び製剤の安定性に非常に優れるものであった。 The emulsion of Example 17 was very excellent in light stability of folic acid that deteriorates due to light, no odor change, no stickiness, and stability of the preparation.
実施例18:目元用乳液
(成分) (質量%)
1.ポリオキシエチレン(20)ソルビタンモノオレート 1.0
2.モノオレイン酸ソルビタン 1.0
3.セトステアリルアルコール 1.0
4.流動パラフィン 5.0
5.2−エチルヘキサン酸トリグリセリル 3.0
6.12−ヒドロキシステアリン酸コレステリル 5.0
7.天然ビタミンE 0.5
8.イソノナン酸イソトリデシル 5.0
9.精製水 残量
10.エデト酸ニナトリウム 0.1
11.パラオキシ安息香酸メチル 0.3
12.フェノキシエタノール 0.5
13.グリセリン 5.0
14.ジプロピレングリコール 10.0
15.ヒドロキシプロリン 0.05
16.ポリビニルアルコール 0.1
17.ジェランガム 0.1
18.エタノール 5.0
19.香料 適量
20.葉酸 0.05
21.トリプトファン 0.2
22.クエン酸 0.02
23.リン酸二水素ナトリウム 0.05
24.水酸化ナトリウム 0.0134
25.精製水 3
Example 18: Eye lotion (component) (mass%)
1. Polyoxyethylene (20) sorbitan monooleate 1.0
2. Sorbitan monooleate 1.0
3. Cetostearyl alcohol 1.0
4). Liquid paraffin 5.0
5. Triglyceryl 2-ethylhexanoate 3.0
6. Cholesteryl 12-hydroxystearate 5.0
7). Natural vitamin E 0.5
8). Isotridecyl isononanoate 5.0
9. Purified water remaining amount 10. Edetate disodium 0.1
11. Methyl paraoxybenzoate 0.3
12 Phenoxyethanol 0.5
13. Glycerin 5.0
14 Dipropylene glycol 10.0
15. Hydroxyproline 0.05
16. Polyvinyl alcohol 0.1
17. Gellan gum 0.1
18. Ethanol 5.0
19. Perfume proper amount20. Folic acid 0.05
21. Tryptophan 0.2
22. Citric acid 0.02
23. Sodium dihydrogen phosphate 0.05
24. Sodium hydroxide 0.0134
25. Purified water 3
(製法)
A:成分1〜8を70℃で加熱溶解する。
B:成分9の一部、10〜16を70℃で加熱溶解後、Aに添加し、乳化する。
C:成分17を、70℃に加熱した成分9の残部で膨潤する。
D:Bを室温まで冷却後、C、成分19〜25を混合したものを添加し、目元用乳液を得た。
(Manufacturing method)
A: Components 1 to 8 are dissolved by heating at 70 ° C.
B: A part of component 9, 10-16, is heated and dissolved at 70 ° C., then added to A and emulsified.
C: Component 17 is swollen with the remainder of component 9 heated to 70 ° C.
D: After cooling B to room temperature, a mixture of C and components 19 to 25 was added to obtain an eye emulsion.
実施例18の目元用乳液は、光により劣化する葉酸の光に対する安定性、変臭のなさ、べたつきの無さ及び製剤の安定性に非常に優れるものであった。 The eye lotion of Example 18 was very excellent in the stability of the folic acid, which deteriorates due to light, to light, no odor change, no stickiness, and the stability of the preparation.
実施例19:美容液(水中油型乳化組成物)
(成分) (質量%)
1.水素添加大豆リン脂質*2 1.0
2.水素添加大豆リゾリン脂質*3 0.5
3.1,3―ブチレングリコール 3.0
4.グリセリン 5.0
5.オレイン酸オレイル 2.0
6.セトステアリルアルコール 0.3
7.モノステアリン酸グリセリル 0.3
8.精製水 20.0
9.葉酸 0.1
10.ヒドロキシプロリン 0.2
11.リン酸一水素ナトリウム 0.05
12.リン酸二水素ナトリウム 0.05
13.水酸化ナトリウム 0.0144
14.エタノール 5.0
15.精製水 残量
16.キサンタンガム 0.02
17.ポリメタクリロイルオキシエチレン
ホスホリルコリン*4 0.1
18.精製水 10.0
*2:NIKKOLレシノールS−10E(日光ケミカルズ社製)
*3:卵黄リゾレシチンLPC−1(キューピー社製)
*4:LIPIDURE
HM−600(日油社製)
Example 19: Cosmetic liquid (oil-in-water emulsion composition)
(Ingredient) (mass%)
1. Hydrogenated soybean phospholipid * 2 1.0
2. Hydrogenated soybean lysophospholipid * 3 0.5
3.1,3-Butylene glycol 3.0
4). Glycerin 5.0
5. Oleyl oleate 2.0
6). Cetostearyl alcohol 0.3
7). Glyceryl monostearate 0.3
8). Purified water 20.0
9. Folic acid 0.1
10. Hydroxyproline 0.2
11. Sodium monohydrogen phosphate 0.05
12 Sodium dihydrogen phosphate 0.05
13. Sodium hydroxide 0.0144
14 Ethanol 5.0
15. Purified water remaining amount 16. Xanthan gum 0.02
17. Polymethacryloyloxyethylene
Phosphorylcholine * 4 0.1
18. Purified water 10.0
* 2: NIKKOL Resinol S-10E (Nikko Chemicals)
* 3: Egg yolk lysolecithin LPC-1 (manufactured by Kewpie)
* 4: LIPIDURE
HM-600 (manufactured by NOF Corporation)
(製法)
A:成分1〜4を70℃で均一に混合する。
B:成分5〜7を70℃で均一に溶解する。
C:成分8を70℃で均一に溶解する。
D:AにBを添加し均一に混合する。
E:DにCを添加し均一に混合する。
F:Eに9〜14を添加し均一に混合する。
G:Fを冷却し15〜18を添加し均一に混合して美容液を得た。
(Manufacturing method)
A: Components 1 to 4 are uniformly mixed at 70 ° C.
B: Components 5 to 7 are uniformly dissolved at 70 ° C.
C: Component 8 is uniformly dissolved at 70 ° C.
D: Add B to A and mix uniformly.
E: C is added to D and mixed uniformly.
F: Add 9 to 14 to E and mix uniformly.
G: F was cooled, 15 to 18 were added, and mixed uniformly to obtain a cosmetic liquid.
実施例19の美容液は、光により劣化する葉酸の光に対する安定性、変臭のなさ、べたつきの無さ及び製剤の安定性に非常に優れるものであった。 The cosmetic liquid of Example 19 was very excellent in the stability of the folic acid that deteriorates due to light to light, no odor change, no stickiness, and the stability of the preparation.
実施例20:油中水型クリーム
(成分) (質量%)
1.ジポリヒドロキシステアリン酸PEG30 0.5
2.グリセリン 10.0
3.1,3―ブチレングリコール 5.0
4.デカメチルシクロペンタシロキサン 15.0
5.トリ2−エチルヘキサン酸グリセリル 5.0
6.ポリエチレンテレフタレート粉末 3.0
7.精製水 残量
8.葉酸 0.1
9.リジン 0.2
10.リン酸一水素ナトリウム 0.05
11.リン酸二水素ナトリウム 0.05
12.水酸化ナトリウム 0.0144
13.エデト酸ニナトリウム 0.1
14.防腐剤 適量
15.ジメチルジステアリルアンモニウムヘクトライト 0.5
16.エタノール 2.0
17.香料 適量
Example 20: Water-in-oil cream (component) (mass%)
1. Dipolyhydroxystearic acid PEG30 0.5
2. Glycerin 10.0
3.1,3-Butylene glycol 5.0
4). Decamethylcyclopentasiloxane 15.0
5. Glyceryl tri-2-ethylhexanoate 5.0
6). Polyethylene terephthalate powder 3.0
7). Purified water remaining amount 8. Folic acid 0.1
9. Lysine 0.2
10. Sodium monohydrogen phosphate 0.05
11. Sodium dihydrogen phosphate 0.05
12 Sodium hydroxide 0.0144
13. Edetate disodium 0.1
14 Preservative appropriate amount15. Dimethyl distearyl ammonium hectorite 0.5
16. Ethanol 2.0
17. Perfume
(製法)
A:成分1〜3を70℃で加熱溶解する。
B:成分4〜6を70℃で加熱溶解後、Aに添加混合する。
C:成分7〜14を70℃で加熱溶解後、Bに添加し乳化する。
D:Cを室温まで冷却後、成分15〜17を添加し、油中水型クリームを得た。
実施例20の油中水型クリームは、光により劣化する葉酸の光に対する安定性、変臭のなさ、べたつきの無さ及び製剤の安定性に非常に優れるものであった。
(Manufacturing method)
A: Components 1 to 3 are heated and dissolved at 70 ° C.
B: Components 4 to 6 are heated and dissolved at 70 ° C., and then added to A and mixed.
C: Components 7 to 14 are heated and dissolved at 70 ° C., then added to B and emulsified.
D: After cooling C to room temperature, ingredients 15 to 17 were added to obtain a water-in-oil cream.
The water-in-oil cream of Example 20 was very excellent in the stability of folic acid that deteriorates due to light to light, no odor change, no stickiness, and the stability of the preparation.
実施例21:リキッドファンデーション
(処方) (質量%)
1.ワセリン 7.0
2.流動パラフィン 5.0
3.ステアリン酸 2.0
4.セタノール 1.0
5.ゴマ油*6 0.5
6.大豆リン脂質 0.5
7.パラメトキシケイ皮酸−2−エチルヘキシル 3.0
8.グリセリン 5.0
9.トリエタノールアミン 1.0
10.カルボキシメチルセルロース 0.7
11.葉酸 0.1
12.リジン 0.2
13.リン酸一水素ナトリウム 0.05
14.リン酸二水素ナトリウム 0.05
15.精製水 残量
16.酸化チタン 8.0
17.微粒子酸化チタン 2.0
18.酸化亜鉛 5.0
19.マイカ 5.0
20.タルク 6.0
21.着色顔料 6.0
22.ホオウ抽出物*7 0.5
23.香料 適量
*6:日清製油社製
*7:丸善製薬社製
Example 21: Liquid foundation (formulation) (mass%)
1. Vaseline 7.0
2. Liquid paraffin 5.0
3. Stearic acid 2.0
4). Cetanol 1.0
5. Sesame oil * 6 0.5
6). Soy phospholipid 0.5
7). Paramethoxycinnamic acid-2-ethylhexyl 3.0
8). Glycerin 5.0
9. Triethanolamine 1.0
10. Carboxymethylcellulose 0.7
11. Folic acid 0.1
12 Lysine 0.2
13. Sodium monohydrogen phosphate 0.05
14 Sodium dihydrogen phosphate 0.05
15. Purified water remaining amount 16. Titanium oxide 8.0
17. Fine particle titanium oxide 2.0
18. Zinc oxide 5.0
19. Mica 5.0
20. Talc 6.0
21. Coloring pigment 6.0
22. Buffalo extract * 7 0.5
23. Perfume appropriate amount * 6: Nisshin Oil Co., Ltd. * 7: Maruzen Pharmaceutical Co., Ltd.
(製法)
A.成分1〜7を混合溶解する。
B.Aに成分16〜21を加え、均一に混合し、70℃に保つ。
C.成分8〜15を均一に溶解し、70℃に保つ。
D.BにCを添加して、均一に乳化する。
E.Dを冷却後、成分22〜23を添加してリキッドファンデーションを得た。
(Manufacturing method)
A. Components 1 to 7 are mixed and dissolved.
B. Ingredients 16-21 are added to A, mixed uniformly and kept at 70 ° C.
C. Ingredients 8-15 are dissolved uniformly and kept at 70 ° C.
D. C is added to B and emulsified uniformly.
E. After cooling D, components 22 to 23 were added to obtain a liquid foundation.
実施例21のリキッドファンデーションは、光により劣化する葉酸の光に対する安定性、変臭のなさ、べたつきの無さ及び製剤の安定性に非常に優れるものであった。 The liquid foundation of Example 21 was very excellent in the stability of folic acid that deteriorates due to light to light, no odor change, no stickiness, and the stability of the preparation.
実施例22:水中油型軟膏剤
(処方) (質量%)
1.ステアリン酸 18.0
2.セタノール 4.0
3.酢酸dl−α―トコフェロール 0.2
4.トリエタノールアミン 2.5
5.グリセリン 5.0
6.グリチルリチン酸ジカリウム 0.5
7.葉酸 0.2
8.リジン 0.3
9.パラオキシ安息香酸メチル 0.1
10.精製水 残量
Example 22: Oil-in-water ointment (formulation) (mass%)
1. Stearic acid 18.0
2. Cetanol 4.0
3. Dl-α-tocopherol acetate 0.2
4). Triethanolamine 2.5
5. Glycerin 5.0
6). Dipotassium glycyrrhizinate 0.5
7). Folic acid 0.2
8). Lysine 0.3
9. Methyl paraoxybenzoate 0.1
10. Purified water remaining
(製法)
A.成分1〜3を加熱混合し、75℃に保つ。
B.成分4〜10を混合し、75℃に保つ。
C.AにBを徐々に加え、軟膏剤を得た。
(Manufacturing method)
A. Ingredients 1-3 are heated and mixed and maintained at 75 ° C.
B. Ingredients 4-10 are mixed and kept at 75 ° C.
C. B was gradually added to A to obtain an ointment.
実施例22の軟膏は、光により劣化する葉酸の光に対する安定性、変臭のなさ、べたつきの無さ及び製剤の安定性に非常に優れるものであった。 The ointment of Example 22 was very excellent in the stability of the folic acid that deteriorates due to light to light, no odor change, no stickiness, and the stability of the preparation.
実施例23:錠剤
(処方) (質量%)
1.乳糖 24.0
2.結晶セルロース 20.0
3.コーンスターチ 15.0
4.葉酸 0.2
5.リジン 0.1
6.アルギニン 0.05
7.ヒドロキシプロリン 0.05
8.トリプトファン 0.05
9.クエン酸 0.1
10.デキストリン 残量
11.グリセリン脂肪酸エステル 5.0
12.二酸化ケイ素 1.0
Example 23: Tablet (prescription) (mass%)
1. Lactose 24.0
2. Crystalline cellulose 20.0
3. Corn starch 15.0
4). Folic acid 0.2
5. Lysine 0.1
6). Arginine 0.05
7). Hydroxyproline 0.05
8). Tryptophan 0.05
9. Citric acid 0.1
10. Dextrin remaining amount 11. Glycerin fatty acid ester 5.0
12 Silicon dioxide 1.0
(製法)
A.成分1〜12を均一に混合し、常法に従って錠剤を得た。
(Manufacturing method)
A. Components 1 to 12 were mixed uniformly, and tablets were obtained according to a conventional method.
実施例23の錠剤は、光により劣化する葉酸の光に対する安定性、変臭のなさ、及び製剤の安定性に非常に優れるものであった。 The tablet of Example 23 was very excellent in the stability to light of folic acid that deteriorates due to light, no odor change, and the stability of the preparation.
実施例24:清涼飲料
(処方) (質量%)
1.果糖ブドウ糖液糖 30.0
2.乳化剤 0.5
3.葉酸 0.001
4.リジン 0.002
5.クエン酸ナトリウム 0.01
6.香料 適量
7.精製水 残量
(製法)
Example 24: Soft drink (prescription) (mass%)
1. Fructose dextrose liquid sugar 30.0
2. Emulsifier 0.5
3. Folic acid 0.001
4). Lysine 0.002
5. Sodium citrate 0.01
6). Perfume appropriate amount 7. Purified water remaining amount (production method)
A.成分1〜7を均一に混合し、常法に従って清涼飲料を得た。 A. Components 1 to 7 were mixed uniformly, and a soft drink was obtained according to a conventional method.
実施例24の清涼飲料は、光により劣化する葉酸の光に対する安定性、変臭のなさ、及び製剤の安定性に非常に優れるものであった。 The soft drink of Example 24 was very excellent in the stability of folic acid that deteriorates due to light to light, no odor change, and the stability of the preparation.
本発明によれば、官能(風味・味・感触等)・安全性を損ねず、葉酸の劣化を抑制するための方法を提供することができる。また、葉酸の安定性を高めた組成物を提供することができる。本発明の組成物は、皮膚外用剤又は化粧料として好適に用いることができる。 ADVANTAGE OF THE INVENTION According to this invention, the method for suppressing deterioration of a folic acid can be provided, without impairing sensory (flavor, taste, touch, etc.) and safety. Moreover, the composition which improved stability of folic acid can be provided. The composition of the present invention can be suitably used as a skin external preparation or cosmetic.
Claims (7)
(A)葉酸
(B)リジン、アルギニン、トリプトファン、ヒドロキシプロリン及びこれらの塩から選ばれる1種以上を配合することを特徴とする葉酸含有組成物であって、
前記成分(A)の配合量が、0.01〜0.2%であり、
前記成分(B)の配合量が、0.05〜1%であり、
前記組成物が、皮膚外用剤又は化粧料である、葉酸含有組成物。 The following components (A) and (B);
(A) Folic acid (B) A folic acid-containing composition comprising one or more selected from lysine, arginine, tryptophan, hydroxyproline and salts thereof,
The amount of the component (A) is 0.01 to 0.2%,
The blending amount of the component (B) is 0.05 to 1%,
A folic acid-containing composition, wherein the composition is an external preparation for skin or a cosmetic.
(A)葉酸
(B)リジン、アルギニン、トリプトファン、ヒドロキシプロリン及びこれらの塩から選ばれる1種以上を配合することを特徴とする皮膚外用剤又は化粧料において、
前記成分(A)の配合量を、0.01〜0.2%とし、
前記成分(B)の配合量を、0.05〜1%とする、皮膚外用剤又は化粧料における、葉酸の安定化方法。 The following components (A) and (B);
(A) Folic acid
(B) In a skin external preparation or cosmetic characterized by blending at least one selected from lysine, arginine, tryptophan, hydroxyproline and salts thereof,
The amount of the component (A) is 0.01 to 0.2%,
The method for stabilizing folic acid in a skin external preparation or cosmetic, wherein the amount of component (B) is 0.05 to 1% .
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012287329A JP6235779B2 (en) | 2012-03-28 | 2012-12-28 | Folic acid-containing composition and method for stabilizing folic acid |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012072807 | 2012-03-28 | ||
| JP2012072807 | 2012-03-28 | ||
| JP2012287329A JP6235779B2 (en) | 2012-03-28 | 2012-12-28 | Folic acid-containing composition and method for stabilizing folic acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013227274A JP2013227274A (en) | 2013-11-07 |
| JP6235779B2 true JP6235779B2 (en) | 2017-11-22 |
Family
ID=49675323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012287329A Active JP6235779B2 (en) | 2012-03-28 | 2012-12-28 | Folic acid-containing composition and method for stabilizing folic acid |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6235779B2 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6865527B2 (en) * | 2016-01-12 | 2021-04-28 | 共栄化学工業株式会社 | Composition |
| JP2017143801A (en) * | 2016-02-18 | 2017-08-24 | 三菱ケミカル株式会社 | Plant cultivation method |
| JP7232815B2 (en) * | 2017-08-16 | 2023-03-03 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | Stable lyophilisate containing 5,10-methylene-(6R)-tetrahydrofolic acid |
| JP7395623B2 (en) * | 2019-06-26 | 2023-12-11 | ユーグゥァン ヂョン | Omnidirectional skin care mask with variable shape |
| CN115434158B (en) * | 2021-06-05 | 2023-11-10 | 海宁德易遮阳科技有限公司 | Preparation method of antibacterial blackout curtain fabric |
| AU2023282347A1 (en) * | 2022-06-08 | 2025-01-16 | Merck Patent Gmbh | Compositions comprising disodium 5,10-methylene-(6r)-tetrahydrofolate |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58190380A (en) * | 1982-04-30 | 1983-11-07 | Suntory Ltd | Drink containing folic acid and its preparation |
| DE4341000A1 (en) * | 1993-12-02 | 1995-06-08 | Beiersdorf Ag | Use of L-arginine, L-ornithine or L-citrulline and topical preparations with these substances |
| DE4341001A1 (en) * | 1993-12-02 | 1995-06-08 | Beiersdorf Ag | Topical preparations containing L-arginine |
| JP4162306B2 (en) * | 1997-09-25 | 2008-10-08 | 株式会社大塚製薬工場 | Infusion for central venous administration |
| DE10062401A1 (en) * | 2000-12-14 | 2002-06-20 | Beiersdorf Ag | Use of folic acid and / or derivatives thereof for the preparation of cosmetic or dermatological preparations for the prophylaxis of damage to the skin's own DNA and / or to repair damage already occurred to the skin's own DNA |
| TWI474840B (en) * | 2008-10-22 | 2015-03-01 | Ajinomoto Kk | Total nutrition infusion solution |
| EP2391424B1 (en) * | 2009-01-30 | 2016-12-28 | Beiersdorf AG | Cosmetic or dermatological preparation comprising cell growth promoting peptide and cellular complex |
| JP5552763B2 (en) * | 2009-07-01 | 2014-07-16 | 株式会社大塚製薬工場 | Infusion formulation for peripheral intravenous administration |
| WO2011040082A1 (en) * | 2009-09-30 | 2011-04-07 | 株式会社資生堂 | Laminin-332 production accelerating composition |
| KR101782547B1 (en) * | 2010-02-26 | 2017-09-27 | 유니버시다드 데 나바라 | Nanoparticles for the encapsulation of compounds, preparation thereof and use of same |
| BR112013000675B1 (en) * | 2010-07-16 | 2021-07-20 | Universidad De Navarra | NANOPARTICLE, PROCESS FOR PRODUCING A NANOPARTICLE COMPRISING A ZEIN MATRIX AND A BASIC AMINO ACID, COMPOSITION AND FOOD PRODUCT |
-
2012
- 2012-12-28 JP JP2012287329A patent/JP6235779B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013227274A (en) | 2013-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5479891B2 (en) | Novel royal jelly fraction, its production method and use | |
| JP3810836B2 (en) | Cosmetic composition for beauty | |
| JP5571280B2 (en) | Sebum production promoter | |
| ES2638046T3 (en) | Compositions to relieve damage induced by ultraviolet radiation | |
| JP2008280271A (en) | Skin photoaging prevention agent | |
| JPWO2008062861A1 (en) | Cyanobacteria extract powder, method for producing the same, and use of Cyanobacteria extract powder | |
| JP6235779B2 (en) | Folic acid-containing composition and method for stabilizing folic acid | |
| JP5468757B2 (en) | Composition having fibroblast proliferation promoting ability | |
| JP2012092085A (en) | Anti-skin photoaging agent using coprinus comatus and extract thereof | |
| ES2677618T3 (en) | Composition to mitigate damage induced by ultraviolet radiation | |
| JP2009263279A (en) | Elastase inhibitor | |
| US20090269424A1 (en) | Peripheral blood flow-improving composition | |
| JP2008088123A (en) | Skin care composition | |
| JP2002212087A (en) | External preparation for skin | |
| JP2012036128A (en) | Collagen production promoter and skin-beautifying composition comprising the same | |
| JP4363841B2 (en) | Method for improving solubility of polyphenol in water and aqueous solution containing polyphenol | |
| JP6781529B2 (en) | Skin care cosmetic composition | |
| JP4849792B2 (en) | Cosmetic composition | |
| JP6909569B2 (en) | Skin quality improver | |
| JP6800474B2 (en) | Nutrient absorption improver | |
| JP6529119B2 (en) | Nrf2-related gene expression promoter | |
| JP2008074816A (en) | In vivo antioxidants | |
| JP2002047193A (en) | Composition for preventing or treating allergic dermatitis | |
| JP2005029483A (en) | Active oxygen-eliminating agent, and cosmetic and food and drink | |
| JPH104953A (en) | Composition for beauty and health using melatonin yeast |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20151221 |
|
| RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20151221 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20161031 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20161108 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170106 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170704 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20170901 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170915 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20171003 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20171027 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6235779 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |